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Cancer remains the second most common cause of death in the United States. It is therefore 
imperative that a lot of effort be put into finding a cure for this dreadful disease that shows no 
discrimination, and virtually anybody is at risk of developing the disease. 
Chapter 1 introduces basic facts about cancer and the available treatments, including PDT and 
BNCT. Our focus will be on these two bimodal therapies, which form the basis of my research 
work, which involves the synthesis of potential sensitizers to be used either in PDT or BNCT or 
both.  
In Chapter 2, I discuss the synthesis of thienyl- appended porphyrins, which have been found to 
absorb at longer wavelengths. This is favorable for PDT applications. In addition to this I 
introduce carborane cages to the porphyrin system to obtain compounds that have high 
10
B 
concentrations and therefore potential boron delivery agents in BNCT. In this chapter I will also 
discuss the photophysical and biological studies of the porphyrins that I have synthesized. 
Chapter 3 reports the synthesis of various carborane substituted oligothiophenes. Using a base, 
the closo carboranes are converted to the open nido cages. Insertion of different metals into these 
cages results in the synthesis of sandwich-type metalla-bis(dicarbollide) compounds, which are 
further electropolymerized to give the corresponding polymers. Both photophysical and 
biological studies of the oligothiophenes are carried out to establish their potential as 
10
B 
delivery agents in BNCT. 
Finally, in chapter 4, I discuss the synthesis of new disubstituted tetrabenzoporphyrins (TBPs). In 
order to increase selectivity of the compounds towards tumor cells, we conjugate the compounds 
to the polyamine, spermine, to the macrocycle.  
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CHAPTER 1: INTRODUCTION 
1.1 Cancer Basics 
Cancer is characterized by uncontrolled growth and spread of abnormal cells (Figure 1-1). When 
the spread of these abnormal cells is not prevented, it can lead to death
1
. Cancer is the second 
most common cause of death after heart diseases. According to the most recent statistics from the 
American Cancer Society, it was estimated that there would be more than 1.5 million new cancer 
cases in the year 2010. In addition to this, it was projected that there would be more than 500,000 
lives lost as a result of cancer. This translated to about 1,500 deaths a day
2
. Most cancer types are 
named after the organ or cell they originate from. In the United States, the most common types 
of cancer include bladder cancer, breast cancer, colon and rectal cancer, endometrial cancer, 
kidney (renal cell) cancer, leukemia, lung cancer, melanoma, non-hodgkin lymphoma, pancreatic 
cancer, prostate cancer and thyroid cancer. Cancer can further be classified into four stages, I-IV, 
depending on the extent of the primary tumor and the extent to which it has spread in the body. 
Staging is critical in cancer diagnosis since it will determine the mode of treatment that will be 
used
3
. The most common types of treatment for cancer include surgery, chemotherapy and 
radiation therapy. Before the development of chemotherapy and radiation therapy, the only 
treatment that was available was the surgical removal of tumors. Development of the 
chemotherapies began in the 1940s, with the use of nitrogen mustards the drugs of choice. 
Nitrogen mustards are strong alkylating agents that have the ability to add alkylating groups onto 
DNA bases, resulting in the destruction of cancer cells
4
. Since then, there has been the 
development of many different drugs that have been used in chemotherapeutics. The modes of 
action of most of these drugs involve the inhibition of DNA replication or interference with its 
function as a way of destroying cancer cells
5




Figure 1-1. Uncontrolled growth of cancer cells
6
 
oncolytic viruses which selectively enter neoplastic cells and replicate in the cells leading to their 
destruction
7
. Despite cancer cells being different from normal cells, they still share the same 
DNA and major metabolic pathways. As a result, the traditional drugs that attack DNA 
replication or cell division in cancer cells, can also attack normal cells. This results in serious 
side effects such as bone marrow and gastrointestinal toxicity which in some cases can prove to 
be life threatening
4
.  As a result, there has been the need for the development of less invasive 
procedures with fewer side effects. A lot of focus has therefore been put on two relatively new 
bimodal therapies, photodynamic therapy (PDT) and boron neutron capture therapy (BNCT).  
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1.2 Photodynamic Therapy (PDT) 
The concept of combining light with a chemical agent dates back to approximately 3000 years 
ago. Ancient Egyptians and Indians used this photochemistry for restoration of pigment in 
vitiligo patients
8
. In modern science however, PDT was first reported over 100 years ago by 
Hermann von Tapiener and his student Oscar Raab, when they discovered that illumination of 
microbial cultures in presence of acridine resulted in cell death. It was not until 1960 that it was 
reported that neoplastic tissues in patients fluoresced under light after administration of a 
photosensitizer
9
. In cancer therapy therefore, visible light, a light sensitive drug (photosensitizer) 
and oxygen are all combined. This leads to production of toxic species which in turn destroy 
tumor tissue
10
. When the photosensitizer absorbs light, it is excited to a short-lived excited 
singlet state (S1) (see Figure 1-2). Through intersystem crossing, this molecule can convert to the 
excited triplet state (T1). To explain the cell destruction process, two different mechanisms, type 
I and type II, are usually invoked. In type I reactions, the photosensitizer in its excited triplet 
state generates free radicals by electron or proton transfer, while in the type II mechanism, 
singlet oxygen (
1
O2) is produced by energy transfer. In both reactions, oxygen is seen as a major 
mediator of cell destruction
11
. 
In the first step in the process of photodynamic therapy, the photosensitizer is administered either 
orally, topically, or intraveneously (see Figure 1-3). This is followed by a period of incubation, 
which allows for the photosensitizer to accumulate in the tumor cells. During this time, the ratio 
of the concentration of the drug in tumor cells to that of normal cells is such that the tumor cells 
have considerably higher concentrations. Depending on the type of photosensitizer, the 
incubation period could range from a few hours to a couple of days. The tumor is then irradiated 
4 
 





Figure 1-2: Mechanism of PDT
12
: 1)Absorption of light 2)Fluorescence 3) Intersystem Crossing 
4) Phorphorescence 5) Hydrogen radical or electron transfer 6) Singlet Oxygen Production 
 





As discussed earlier, only subcellular structures that are labeled by the photosensitizers are 
typically damaged by the photodynamic process. Therefore, the intracellular localization of 
photosensitizers plays a major role in PDT efficiency. A lot of research has been carried out to 
determine the mechanism for the preferential retention of photosensitizers by tumors
14
. Although 
these mechanisms are not fully understood, it has been widely accepted that serum proteins are 
mainly responsible for transportation of photosensitizers throughout the body. It has been shown 
that upon administration into the body, photosensitizers associate mainly with low-density 
lipoproteins (LDL). Several in vitro and in vivo studies have shown that there is an over 
expression of LDL receptors in tumor cells than in normal cells. LDLs therefore play a major 
role in the delivery of hydrophobic and/or ampiphilic photosensitizers to cancerous cells
15
. 
Therefore when designing a photosensitizer for PDT, it is crucial to keep in mind the affinity it 
has for LDL.  
1.3 Classes of Photosensitizers 
Photosensitizers can be classified according to their chemical structure. Table 1-1 lists the 
different families of photosensitizers. The first category consists of compounds that essentially 
are dyes. Pthalocyanines and naphthalocyanine dyes belong to this group, and they have a lot of 
potential as PDT photosensitizers. The second category consists of compounds with a 
chlorophyll and bacterio chlorophyll platform. As expected, these compounds, just like 
chlorophyll, have excellent photosensing properties. This group is comprised of chlorins, 
purpurins and bacteriochlorins. The final category has a porphyrin platform. This is perhaps the 
most promising group of all, and is evidenced by the number of clinical photosensitizers that are 
based on this platform
16
(see Table 1-1). While there are many compounds that can act as 
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photosensitizers, very few are commercially available. Table 1-2
16
 lists various clinical 
photosensitizers that are currently available. 
Table 1-1. The categories of photosensitizers
16
 
Porphyrin Platform Chlorophyll and Bacteriochlorophyll 
Platform 
Dyes 
HpD Chlorins Phthalocyanines 
HpD-based Purpurins Napthalocyanines 
BPD Bacteriochlorins ALA 
  Texaphyrins 
 
Table 1-2: Photosensitizers clinically available for PDT
16
 
Drug Substance Manufacturer Cancer Treated 
Photofrin® HpD Axcan Pharma, Inc Esophageal, Colon and 





Age related macular 
degeneration 
Metvix® M-ALA PhotoCure ASA Skin, neck, head 
Levulan® ALA DUSA Pharmaceuticals, 
Inc. 
Skin, bladder, actinic keratosis 








Table 1-2 continued 
Drug Substance Manufacturer Cancer Treated 
Foscan® Temoporfin Biolitec Pharma Ltd. Cutaneous lesions, 
esophageal, head, 
neck 
LS11 Talaporfin Light Science Ongoing clinical 
studies 
Photochlor HPPH RPCI Barrett‟s esophagus, 
lung 




lesions, lip, pharynx, 










Figure 1-4 cont‟d 
 
As seen, most of the photosensitizer drugs currently available are based on a porphyrin platform. 
This can be attributed to a number of key photophysical, photochemical, and biological 
properties that they possess. Studies have shown that porphyrins absorb strongly in the visible 
region of the optical spectrum, they are fluorescent, and generally non- toxic in the dark. In 
addition to this, they have been found to have a high affinity for serum proteins thereby 
enhancing their selectivity for tumors. They have been found to exhibit chemical stability, both 
as free or metal-complexed compounds while retaining their in vivo tumor-localization. Finally, 
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they have been shown to localize in subcellular structures, lysosomes, endoplasmic reticulum, 
mitochondria and golgi apparatus
17
. Even though PDT provides a non-invasive procedure in the 
cure of cancer, there are some drawbacks that are associated with the process. The first major 
hurdle that needs to be overcome is the fact that normal cells are also destroyed in the process of 
killing the tumor cells. This can be addressed by finding ways of improving the selectivity of the 
photosensitizers in the tumor. It has also been reported that after this procedure, some patients 
experience photosensitive skin, which could last from a few hours to several weeks. This is 
brought about by the photosensitizer not clearing fast enough from the body
18
. Evidently, a lot of 
work still needs to be done to improve this promising relatively new cancer therapy. 
1.4 Boron Neutron Capture Therapy (BNCT) 
As mentioned earlier, surgery, chemotherapy, and radiation therapy are conventional approaches 
to the treatment of cancer. In case of solid tumors, surgery is the preferred method for removal of 
the tumor. However there is always a bit of uncertainty as to whether all the cancerous cells were 
removed or not. As a result, there is always the possibility of recurrence of the tumor. 
Chemotherapy and radiotherapy offer alternative means of destroying cancer cells. In the case of 
chemotherapy, the major drawback is that the destructive effects of the drugs used are not limited 
to the tumor cells only, as normal cells are also destroyed. In radiotherapy, the radiation used to 
destroy tumors is usually so strong that normal cells are also killed. To make matters worse, in 
both chemotherapy and radiotherapy, the toxic effects on normal cells are irreversible
19
. 
Evidently, there has been a need to develop better strategies to combat cancer. This has led to the 





, photodynamic therapy (PDT)
17





1.5 Fundamental Properties of Nuclides 
Neutrons are uncharged nuclear particles which have an atomic mass of 1 and energy of 
0.025eV. Their most important property with respect to radiation is that they only react with 
nuclei and not electrons. This interaction proceeds via scattering and absorption. NCT is 
therefore based on the ability of some nuclides, both radioactive and non-radioactive to absorb 
thermal or slow neutrons. These nuclear events liberate lethal particles that possess large 
amounts of energy. A measure of the probability of neutrons being captured by a nuclide is given 






 lists the nuclides 
with high capture cross sections. 
Table 1-3: Cross section values of selected nuclides for thermal neutrons 
Nuclide Cross section 
(barn) 













































































 Table 1-3 continued 
















The capture cross section and subsequently the reactions arising from them is different for each 
nuclide. Therefore, even for isotopes of the same elements, the capture cross sections greatly 
differ. When compared to the capture cross section values of tissue elements, (Table 1-4
19
), it can 
be seen that these values are at least 2 orders of magnitude greater. 
The capture cross-section, however, is just one aspect that is considered when choosing nuclides 
for use in NCT. Another very important point to take into consideration is whether the toxic 
radiation produced during the fission process is confined in the cell. If this is not achieved, then 





Li as potential nuclides for neutron capture. However, it was soon discovered, that 
235




Li being an alkali metal, 
under biological conditions, its compounds would readily be broken down to lithium cations
19
. In 
addition to its high capture cross section, studies have shown that when irradiated with low- 
energy thermal neutrons, 
10





 as shown is Scheme 1-1. These fragments have mean free pathways of travel in tissue 
(5-9μm) which is approximately equivalent to the diameter of mammalian cells. This means that 
they can bring about confined biological damage through ionization
19, 25
. In addition to this, 
10
B 
can take part in reactions that lead to the synthesis of different compounds which have 
remarkably stable linkages with other atoms, like carbon, nitrogen, and oxygen
21
. Based on all 
12 
 
these attractive properties, a lot of effort has been put into development of BNCT, with the 
primary focus being on the treatment of high- grade gliomas and either cutaneous primaries or 




Scheme 1-1: Fission reactions that occur upon boron capture of neutrons 
Successful treatment using BNCT depends on the selective delivery of the sensitizers to the 
tumor and the possibility of achieving sufficiently high endocellular boron concentration
24a, 24c
. 
Studies have shown that the amount of boron necessary for effective BNCT is between 15 and 
30μg of 10B per gram of tumor, depending on its exact location within the tumor
24b
. As 
expected, the required concentration of 
10
B for effective BNCT decreases as the position of the 
10
B nuclei is changed from the external cell wall to the cytoplasm to the nucleus of the cell
22d
.  
Approximately 2% of all cancer deaths are caused by primary cerebral tumors, with about 13,000 
people dying each year in the Unites States
2, 26
. In 1951, Dr. William H. Sweet, a neurosurgeon, 
suggested the use of BNCT in treatment of brain tumors, in particular, glioblastoma 
multiforme
19, 27
. The initial clinical trials were not successful mainly due to inadequacies in the 
neutron beams, and the boron compounds that were used, which offered no selectivity to tumor 
cells. There was however renewed interest in the therapy after more encouraging results by Dr. 
Hiroshi Hatanaka for malignant gliomas
28





. The process of treatment using BNCT starts by directing a beam of neutrons 
towards a patient‟s head. These neutrons rapidly lose energy as they pass through tissue, by 
elastic scattering. Consequently, they are captures by 
10
B atoms, which are in turn excited and 
converted to 
11
B atoms for a very short time    10
-12
 seconds). This is followed by fission of 
11
B 
to produce α particles, 
7
Li recoil nuclei and gamma rays. The α particles produced are 
responsible for the selective destruction of tumor cells
31
 (Figure 1-4). 
1.6 Boron Delivery Agents 
For BNCT to be successful, not only must there be a sufficient number of 
10
B atoms that are 
selectively accumulated in the tumors, but the concentration gradient of 
10
B atoms between the 
tumors and surrounding normal cells must be large
30
.  The priority for the last   50 years has 
therefore been the development of boron delivery agents for BNCT. For a boron delivery agent 
to be considered successful, it must exhibit low toxicities in normal tissue, with high tumor 
uptake and high tumor/brain and tumor/blood concentration ratios (> 3-4: 1). In addition to this, 
the agent must be able to supply 
10
B concentrations between 10 - 30μg 
10
B per gram of tumor. 
Finally, during BNCT, there should be rapid clearance of the agent from blood and normal 
tissues, while maintain the concentrations in tumor cells
31
. To date, only two boron- containing 
drugs have been used clinically for BNCT of brain tumors, (L)-4-dihydroxy-borylphenylalanine 
(BPA) and sodium mercaptoundecahydro-closo-dodecaborate (BSH) (Figure 1-5). These drugs 







Figure 1-4: The process of boron neutron capture therapy in treatment of brain tumors
32
 
Figure 1-5: BNCT compounds that have undergone clinical trials 
A lot of research work has been put into developing boron rich compounds for BNCT. Figure 1-
6 show some BNCT agents that have been synthesized. These include compounds 9 and 10 
which have caborane cages linked to nucleosides, and they have both shown promise in animal 
models. The trimethoxyindole 11 has shown promise in vitro studies, while porphyrin 12 has 





Our research work focuses on the synthesis, characterization, photophysical and biological 
studies of compounds that are potential PDT and BNCT agents. In one project, our main focus is 
the introduction of thiophene groups at the meso position of the porphyrin macrocylce (Scheme 
1-2). The first and obvious reason for this is to extend the conjugation, and therefore shift the 
wavelength of absorption to longer wavelength. The second reason is based on the fact that 
thiophene rings are very stable chemically, and many different reactions can be on the free α-
carbon of the ring. In fact, one of the modifications that we perform is the introduction of 
carboranes to the porphyrin system via the free α-carbon of the thiophene. This introduces many 
attractive properties to the system due to the carborane, and it makes the compounds potential 
agents for both PDT and BNCT. 
 
 




Scheme 1-2: Synthesis of thienyl-appended porphyrins 
 In the second project, we synthesize carborane appended oligothiophenes (Scheme 1-3). Not 
only can these compounds be used in BNCT because of the presence of the carborane ring, but 
also because of their small size we anticipate that they will readily cross the blood brain barrier 
(BBB) to facilitate treatment of brain tumors. In addition to this, we prepared several metal 
complexes of the oligothiophenes, which were further electropolymerized to form 
polythiophenes. These polymers have potential applications in medicine and material science. 
 
Scheme 1-3: Synthesis of carboranyl functionalized thiophenes 
The third project focuses on synthesis of tetrabenzoporphyrins (TBP) (Scheme 1-4), which 
belong to the family of π-extended porphyrins. This group of porphyrins absorb at longer 
wavelength due to their extended conjugation. As potential photosensitizers for PDT, these 
compounds are expected to have good selectivity for tumor cells. To enhance their selectivity, 
17 
 
we introduce polyamine chains to the system. We specifically use spermine, which is found in 
mammalian cells and has been found to take part in key roles in cellular functions.  
 
Scheme 1-4: Synthesis of tetrabenzoporphyrins  
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CHAPTER 2: SYNTHESIS OF THIENYL-APPENDED PORPHYRINS FOR 
PDT AND BNCT 
2.1 Introduction  
For centuries, porphyrins have drawn much attention in the science community due to their wide 
range of applications in the fields of medicine, biochemistry, biology, and chemistry. This can be 
attributed to their fascinating chemical, physical, and spectroscopic properties
1
. It is therefore not 
surprising that in the last century, several Nobel prizes were awarded in the field of tetrapyrrole 
science
2
. Porphyrins are aromatic macrocycles made up of four “pyrrole- type” rings joined by 
four methine carbons
3
. In the UV-Visible spectrum, they are characterized by the presence of an 
intense Soret band1 at  400 nm and several weaker bands, found between 450 nm and 800 nm. 
Porphyrins contain 22 π-electrons, of which 18 are involved in the delocalization pathway, see 
Figure 2-1. Trans-NHs are the most favored tautomeric forms, while the cis-NH tautomers are 




Figure 2-1: Delocalization Pathway of Porphyrins 
 
Because of their many applications, much focus has been directed towards porphyrin synthesis, 
which involves the arrangement of different substituents about the periphery of the macrocycle. 
Generally speaking, the electronically most reactive sites at the periphery of the porphyrin 
macrocycle are the 5, 10, 15 and 20 positions, which are designated as the meso positions. 
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However, in the presence of bulky reactant species, the β-pyrrolic 2, 3, 7, 8, 12, 13, 17 and 18 
positions are the preferred reaction sites
4(Figure 2-1). Therefore there are two distinct types  of 
substituents at the porphyrin periphery, the β-substituted porphyrins and meso-substituted 
porphyrins, with the former having a close resemblance to naturally occurring porphyrins (Figure 
2-2). Meso-substituted porphyrins have gained popularity due to their ease of synthesis, as well 
as the ability to design elaborate and highly sophisticated groups at the meso position. As a 
result, they have found applications as biomimetic models and also form an integral part in 
materials science
1
. Several synthetic methods for meso-substituted porphyrins have been 
developed, and these include, the Rothemund, Adler and Lindsey methods. 
 
Figure 2-2: Three types of porphyrins 
2.2 Methods for Porphyrin Synthesis 
Synthesis of meso-porphyrins was initiated by Rothemund in 1935
5
.  He carried out the 
syntheses by reacting different aldehydes with pyrroles at very high temperatures. The most 
notable porphyrin synthesized using this method was tetramesitylporphyrin (H2TMP). This was 
obtained by reaction of mesitaldehyde and pyrrole in presence of pyridine solvent, at 180
o
C for 
48 h. It was found that the methyl groups in Fe
II





 . Despite several variations by different research groups
7
, this method has not 
received much application. This is largely due to the low overall yields obtained.  
The Adler method was developed by Adler, Longo, and co-workers in the mid 1960s
8
. This 
method basically requires the use of acidic solvents at reflux conditions in an open atmosphere. 
Of the three acids used (propionic acid, acetic acid and acidified benzene) propionic acid is the 
most preferred leading to overall yields of the porphyrins, ranging between 20 and 40%
1
. This is 
obviously better than the Rothemund method. In addition to the high yields, another attractive 
feature of this method is the fact that the porphyrin product can often crystallize out of the cooled 
acidic solvent. A major drawback however, is the limit in the types of aldehydes that can be used 
in this synthesis. Many aldehydes with substituents that are sensitive to acids cannot be used to 
prepare porphyrins using this method, and as a result, extra steps of protection and deprotection 
of the substituents have to be employed
9
. Both the Rothemund and Adler methods have 
limitations in their applications, in part due to the harsh reaction conditions that are necessary for 
porphyrin synthesis. This in turn affects the yields of the final product. Secondly, these two 
methods do not present a rational method of accessing porphyrins, especially those, with two, 
three or four distinct meso-substituents. There was clearly a need to develop a new method that 
could not only accommodate a wide range of functional groups, but could also lead to a variety 
of porphyrins with different number of distinct substituents. 
 In the early 1980s, Lindsey and co-workers developed the Lindsey protocol which facilitated the 
synthesis of porphyrins under mild conditions. This method takes advantage of the highly 
reactive aldehyde and pyrrole starting materials, which do not require harsh conditions to react. 
The mild conditions include condensation of the aldehyde and pyrrole in the presence of an acid 
catalyst, normally trifluoroacetic acid (TFA) or BF3.OEt2, at room temperature to form a 
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porphyrinogen intermediate. This step is followed by the addition of an oxidant, usually p-
chloranil or 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ), to afford the more stable 
aromatic porphyrin
10
. The major disadvantage here is that dilute concentrations of aldehyde and 
pyrrole are required to minimize the competition between oligomerization of pyrromethanes and 
cyclization to give the porphyrinogen
11
(Scheme 2-1). This means that when running large scale 
synthesis of porphyrins, one has to handle large amounts of solvents. In addition to this, the 








2.3 Thienyl- substituted Porphyrins 
Reports on porphyrins with 5-membered heterocycles, such as pyrrole, furan and thiophene, as 
substituents at the meso position are scarce
12
. However, meso-tetrathienyl porphyrins have 
incited much interest due to their use as models for energy transfer reactions as well as for their 
conductivity
13
. In 1968, Triebs and co-workers reported the synthesis of the first thienyl 
substituted porphyrin. This was achieved using the Rothemund method and the porphyrin was 
obtained in 9% yield
14
. Torréns and co-workers and Bhyrappa and Bhavana later prepared the 
same porphyrin using the Adler-Longo method, with the latter reporting a yield of 14%
13, 15
. 
Since then, most studies on this group of porphyrins have adapted the Lindsey protocol, mainly 
due to the mild reaction conditions involved in the synthesis which the thienyl groups can 
withstand
16
. Despite the fact that the photophysical and electronic properties of thienyl 
porphyrins have been studied, there appears to be inconsistencies in describing the effect of the 
thienyl ring on the electronic properties of the porphyrin molecules
16a
. Compared to the 
corresponding tetraphenyl-porphyrin, thienyl-porphyrins show red-shifted absorption bands. In 
addition to this, the shift increases with increased number of thiophene rings. For a long time, it 
was accepted that this red shift in absorption was due to inductive effects of the thiophene rings. 
This arose from the expectation that the small ring size of thiophene would be almost co-planar 
with the porphyrin macrocycle. However, it was found that the dihedral angle formed between 
the porphyrin plane and the thienyl ring was greater in metal complexed thienyl porphyrins, 
compared to metal-complexed tetraphenyl- porphyrins. This means that the effective conjugation 
between the thiophene ring and the porphyrin macrocycle in the thienyl-porphyrin is small
13
. 
Studies carried out by Gupta and Ravikanth
12, 17
 showed that the shift was rather due to a greater 
π-delocalization of thienyl-porphyrins brought about by a strong resonance interaction between 
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the porphyrin macrocycle and the thienyl group(s). In general, the introduction of thienyl 
group(s) on the porphyrin macrocycle allows extension of the π-conjugated system. This in turn 
imparts fascinating electrochemical properties, making these systems ideal building blocks for 
not only linear porphyrin arrays, but also supramolecular assemblies. To date, thienyl- polymers 




2.4 Synthesis of trans- Substituted Porphyrins 
Meso-substituted porphyrins possessing substituents in a trans-configuration have been used as 
building blocks in the preparation of a wide range of systems. There are two ways in which these 
compounds can be prepared. The first is a mixed aldehyde condensation of pyrrole and two 
different aldehydes. This procedure affords up to six different porphyrins, with trans-substituted 
porphyrins present as  12.5% of the total, and cis-substituted porphyrin present as  25% of the 
total. The second and preferred method of preparation of trans-substituted porphyrins involves 
the condensation of a dipyrromethane and an aldehyde, also known as the MacDonald [2 + 2] 
condensation (Scheme 2-2). This method provides a rational approach to the synthesis of trans-
substituted porphyrins with its success relying on the optimization of reaction conditions in order 
to minimize scrambling
1, 18
. Scrambling refers to the formation of different products following 
the initial protonation of dipyrromethane by acid catalyst, whereby a highly reactive species is 
generated. The mechanism of scrambling is illustrated in Scheme 2-3
19
.  
In our research, we focus on the synthesis of meso thienyl-porphyrins, with a trans 
configuration. We use the MacDonald [2 + 2] condensation to prepare the trans substituted 
porphyrins because not only is this method expected to afford better yields than mixed aldehyde 
28 
 
condensations, but it will also make the purification of the porphyrins obtained much easier. We 
anticipate that these 
 
Scheme 2-2: MacDonald 2+2 Condensation 
 
Scheme 2-3: Scrambling of dipyrromethane in the MacDonald[2+2] condensation
19
 
systems will exhibit rich electrochemical and possibly biological properties that will make them 
ideal for both PDT and BNCT. Furthermore, we carry out chemical polymerization on some of 
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the porphyrins, which we expect to lead to polymers with fascinating properties for different 
applications. 
2.5 Results and Discussion 
We began the synthesis with preparation of dipyrromethane, DP-1. This was achieved by 
reacting thiophene-2-carbaldehyde with a large excess of pyrrole in the presence of TFA catalyst 
to afford DP-1 in 64% yield
20
as illustrated in Scheme 2-4.  
 
Scheme 2-4: Synthesis of DP-1 
DP-1 was recrystallized from DCM. The molecular structure of DP-1 is shown in Figure 1. The 
structure is seen to be non-planar. The –NH groups are facing away from each other, with the 





respectively. The thiophene ring is found to be smaller in size compared to the pyrrole ring, as 
seen from the C13-S1-C10 bond, 91.53
o
, compared to C1-N1-C4, 109.80
o
. In addition to this, the 
S-C bonds (S1-C13, 1.6524Å and S1-C10, 1.7212 Å) are found to be longer than N-C bonds 
(N1-C1 = 1.3767 Å, N1-C4 = 1.3770 Å and N2-C6 = 1.3681 Å, N2 = 1.3716 Å). This can be 
attributed to an atom size effect, where S has a larger covalent radius compared to N.  
Using Lindsey‟s protocol, we carried out condensation reactions using different aldehydes, to 
obtain PP1, PP2, PP3, PP4, PP6, PP7 and PP8 in yields between 18% and 56% (see Scheme 2-
5). Reaction conditions had to be optimized to minimize “scrambling” which would have 
resulted in more than one product. As can be seen from Table 2-1, the yields ranged between 
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18% and 56%. PP1 recorded the highest yield. This is expected because only one porphyrin can 
be obtained from this reaction. During the purification of PP3 and PP4, it was observed that in 
both cases, 2 other products were obtained (see Scheme 2-5). 
 
 




Scheme 2-4: Synthesis of PP1-PP7 
 
Table 2-1: List of Porphyrins synthesized and the yields 

























These were confirmed using NMR and MS experiments. Despite efforts to optimize conditions, 
by changing the ratios of the starting reagents, and purging the reaction solutions with argon for 
longer periods, these products were still available. The minor products in both cases were easily 
purified by silica gel chromatography.  
 








Table 2-2: Percentage yields for minor products PP3’, PP4’, PP3” and PP4” 






Starting with thiophene-2-carbaldehyde, we carried out bromination reaction using one 
equivalent of Br2 to obtain thiophene 1. Reaction of 1 with large excess of pyrrole afforded DP-2 
in 67% yield. DP-2 was condensed with 3,5-ditertbutylbenzaldehyde using Lindsey‟s method to 
afford PP5. The initial attempt to synthesize PP5 included the direct bromination of PP3 using 
NBS. This however, gave a mixture of products, brominated at both the α and β positions of the 
thiophene ring. Separation of the brominated products by silica gel chromatography proved to be 
difficult, and this led to low yields of the product. Better yields were obtained using the strategy 
outlined in Scheme 2-6. 
Unlike the case in PP3 and PP4, no porphyrin minor products in the synthesis of PP6 and PP7 
were observed. The side products that were obtained could not be assigned structures using the 
obtained  S data. A possible reason for this could be that there was “scrambling” during the 
reaction process, and this led to formation of polypyrroles. 
We prepared metal-porphyrin complexes by inserting Zn and Cu metals inside the free bases, 
using Zn(OAc)2 and Cu(OAc)2 respectively. This afforded the corresponding metal complexes in 
quantitative yields. To obtain the Zn-porphyrin complexes, the free bases and excess amount of 




Scheme 2-6: Synthesis of PP5 
 
Purification of the products was achieved by use of silica gel chromatography using DCM as 
eluent. In the case of Cu-porphyrin complexes, the free bases and excess amounts of Cu(OAc)2 
were dissolved in MeOH/DCM (1:3) and stirred overnight at room temperature, and then 
allowed to reflux for 4 hours to push the reaction to completion. Similarly, purification was 




Scheme 2-7: Synthesis of MPP1-MPP7 
 
Table 2-3: Percentage yields for metal-porphyrin complexes 
Zn-Porphyrin % Yield Cu-Porphyrin % Yield 
ZnPP1 54% CuPP1 71% 
ZnPP2 98% CuPP2 94% 
ZnPP3 53% CuPP3 21% 
ZnPP4 41% CuPP4 71% 
ZnPP5 62% CuPP5 59% 
ZnPP6 98% CuPP6 21% 
ZnPP7 72% CuPP7 56% 
 
As stated earlier, we were interested in synthesizing porphyrins for application in BNCT. Boron- 
containing porphyrins were therefore synthesized as shown in schemes 2-9, 2-10, 2-14 and 2-17. 





. Through a nucleophilic opening of the dioxane ring by the phenolate groups, PP8 
was conjugated with compound 2
22
, which was synthesized from commercially available 
COSAN
23
. Purification of the final product was achieved by column chromatography using 1:1 
EtOAc/Hexane to afford PP9 in 60% yield. 
 
Scheme 2-7: Synthesis of Compound 2 
 
 
Scheme 2-8: Deprotection of PP4 to give PP8 
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Scheme 2-9: Synthesis of PP9 
 
PP10 was synthesized from commercially available 3,5-dimethylbromobenzene. Bromination of 
3,5-dimethylbromobenzene with NBS in presence of BPO, a radical initiator, gave 3
24
. 
Compound 3 reacted with 1-lithium-2-methyl-o-carborane, which was prepared in situ, to give 
dicarboranylbromobenzene, 4, in 60% yield
24
. Reaction of 4 with n-BuLi followed by dry DMF 
and acid hydrolysis afforded dicarboranylbenzaldehyde 5, in 55% yield
24
. Finally, aldehyde 6 
was condensed with DP-1 to afford PP10 in 6% yield (see Scheme 2-10). 
In an attempt to synthesize PP11, we started with commercially available 2-ethynylthiophene, as 
shown in Scheme 2-11. This compound was reacted with decarborane in presence of ethyl 
sulfide under reflux to afford 6 in 53% yield
25
. Attempts to introduce a formyl group at position 
5 of the thiophene ring using n-BuLi and dry DMF and also using the Vilsmeier-Haack 
reaction
26
 conditions were unsuccessful. This could be as a result of the strong electron-
withdrawing character of the o-carborane unit which facilitates the metalation of the carborane 
C-H group as shown by Equation 2-1
27
. In addition to this, it has been shown that closo-







Scheme 2-10: Synthesis of PP10 
 
 
Equation 2-1: Metalation of the o-carborane C-H group 
 
The synthesis strategy was changed so that we started with thiophene-2-carbaldehyde. This 
compound was brominated with Br2 to afford 87% of compound 1
29
. Compound 1 was reacted 
with TMSA in a Sonogashira coupling reaction, in the presence of PdCl2(PPh3)2 and CuI 
catalysts to afford 43% of compound 7
30
. Deprotection of 7 using K2CO3 afforded 8 in 87% 
yield
31
. An attempt to add the carborane ring to compound 8 using a similar procedure described 
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in Scheme 2-11 was unsuccessful. Attempts to protect the aldehyde using 1,2-ethanedithiol, as 
described in literature, also proved to be difficult, as a result of formation of products that were 
difficult to purify.  
 
 
Scheme 2-11: Attempted introduction of formyl group on thiophene ring 
 
Compound 8 was then condensed with excess pyrrole in presence of TFA catalyst to afford DP-
3 in 23% yield. Because of the low yield obtained for DP-3 we decided to synthesize the 
dipyrromethane directly from compound 7. This was achieved by reacting 7 with excess pyrrole 
in presence of TFA catalyst to afford DP-4 in 63% yield. Deprotection of the trimethylsilane 
group using K2CO3 afforded DP-3 in 78% yield
31
. Finally reaction of DP-3 with decaborane 
afforded DP-5 in 51% yield. Condensation of DP-5 with 3,5-ditertbutylbenzaldehyde afforded 
PP11 in 34% yield. From the MS data obtained on the other fractions obtained during 
purification, no other porphyrins were obtained. However, we detected presence of unreacted 




Scheme 2-12: Attempted incorporation of carborane on Compound 8 
 
 




Scheme 2-14: Synthesis of PP11 
 
The first attempt in the synthesis of PP12 similarly started with commercially available 5-
bromo-2,2'-bithiophene (see Scheme 2-15). This compound was reacted with TMSA under 
Sonogashira coupling reaction conditions, with PdCl2(PPh3)2 and CuI as the catalysts, to afford 9 
in 47% yield
30
. Deprotection of the trimethylsilane group was achieved by reacting 9 with 
K2CO3 to afford 10 in 80% yield
31
. Using similar conditions described earlier for introduction of 
carborane, 11 was obtained in 73% yield
25
. Attempts to introduce an aldehyde functional group 




Scheme 2-15: Attempted introduction of formyl functional group on Compound 11. 
 
Bromination of  [2,2'-bithiophene]-5-carbaldehyde using Br2 afforded 89% of compound 12
32
 
(Scheme 2-16). Reaction of 12 with TMSA under Sonogashira conditions afforded 37% of 13
30
. 
Condensation of 13 with excess pyrrole afforded 65% of DP-6. This was followed by 
deprotection of the trimethylsilane group to obtain DP-7 in 73% yield
31
. Reaction of DP-7 with 
decaborane under reflux afforded 55% of DP-8
25
. DP-8 was condensed with 3,5-
ditertbutylbenzaldehyde to afford 8% of PP12. 
 




Scheme 2-17: Synthesis of PP12 
 
Synthesis of DP-9 was achieved by reaction of [2,2‟-bithiophene]-5-carbaldehyde with excess 
pyrrole in presence of TFA. This afforded the target product in 64% yield, see Scheme 2-18. DP-
9 was then condensed with 3,5-ditertbutylbenzaldehyde and 3,5-dimethoxybenzaldehyde using 
the Lindsey method to afford PP12 and PP13 in 21% and 18% yields, respectively (see Scheme 
2-19). 
 




Scheme 2-19: Synthesis of PP13 and PP14 
 
Table 2-4: Percentage Yields for PP13 and PP14 




We attempted to polymerize PP5 using Sonogashira coupling reaction conditions as shown in 
Scheme 2-20. We reacted PP5 with commercially available 1,4-diethynylbenzene. Unfortunately 
no polymer was obtained. MS showed that the starting reagents were recovered. It is clear that 
the reaction conditions should be optimized. This can be achieved by either reacting for a longer 




Scheme 2-20: Attempted polymerization of PP5 
 
2.6 Photophysical  Studies 
The maximum wavelengths of absorptions and molar extinction coeffecients for PP1-PP9 in 
toluene and DMF are listed in Tables 2-5 and 2-6. Compared to TPP, the absorption bands of 
thienyl-porphyrins are slightly bathochromically shifted by 3-14 nm, with the biggest shift being 
observed in the cobaltabarborane containing, PP9. These shifts indicate that replacing the six-
membered phenyl ring with a five membered thienyl ring, significantly alters the electronic 
properties of the porphyrin, which leads to a greater π-delocalization of the porphyrin into the 
thienyl group by resonance interaction
33
. A study of the Zn- complexes of the thienyl-porphyrins, 
further indicated that the metal complexes in general showed red-shift Soret bands relative to the 
free bases. This observation is consistent with what has been observed in literature
13
. This can be 
as a result of change in geometry when the Zn metal is inserted inside the porphyrin core, a 
process that leads to the loss of 2H
+
. Thienyl-porphyrins typically exhibit Q-bands in the 550-
800 nm region
34
.The emission data for the thienyl-porphyrin free bases, PP1-PP9, as well as the 
Zn complexes in both toluene and DMF are listed in Tables 2-5, 2-6, 2-7 and 2-8. Both the free 
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bases and the ZnPPs show a considerable red shift in emission bands relative to TPP and 
ZnTPP respectively. When determining quantum yields of unknowns, the common practice is to 
do this by comparing with a standard of known fluorescence yield. In our case, the standard used 
is TPP  ФF = 0.11)
35
 for the free bases, and ZnTPP  ФF = 0.033)
35
 for ZnPPs. Compared to 
TPP, thienyl-porphyrins have been shown to have lower quantum yields
34
. This can be attributed 
to the presence of the heavy atom, sulfur, which quenches fluorescence. In our study, the same 
trend was observed, not only for the free bases, but also for the Zn complexes. One observation 
worth mentioning was the strikingly different quantum yields of PP9 in toluene and DMF. PP9 
showed a quantum yield value of 0.164 in toluene, but a significantly lower value of 0.029 in 
DMF. This correlates with literature findings which showed that in polar solvents, compounds 
containing nido-carboranes exhibited low quantum yields. This has been attributed to presence of 
hydrogen bonding, which enhances non-radioactive decay, and in turn reduced quantum yield
36
. 
CuPPs showed a slightly blue shift in their absorption bands compared to both the ZnPPs and 









 orbital pairs with the porphyrin 
 π,π
ӿ
) excited states. As a result, these complexes do not exhibit the typical fluorescence as in the 







Figure 2-4: UV-Vis Absorption Spectra for PP1 (red), PP2 (green), PP3 (blue), PP4 (purple), 
PP5 (maroon), PP6 (pink), PP7 (yellow), and PP9 (brown) at 6μ  concentration in Toluene 
 
Figure 2-5: Emission Spectra for PP1 (red), PP2 (green), PP3 (blue), PP4 (purple), PP5 
(maroon), PP6 (pink), PP7 (yellow), and PP9 (brown) at 1μ  concentration in Toluene 
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TPP 418 505,539,580,640 644,702(sh) 225, 284 0.11 - 
PP1 421 510,547,588,646 656, 709(sh) 235, 288 0.030 5.62 
PP2 423 516,554,593,649 667, 711(sh) 244, 288 0.009 5.64 
PP3 423 511,547,588,644 654, 711(sh) 231, 288 0.043 5.65 
PP4 425 514,559,589,647 664, 712(sh) 239, 287 0.015 5.06 
PP5 425 514,553,590,646 659, 711(sh) 234, 286 0.027 5.58 
PP6
a 428 516,558,595,654 674 246 0.015 5.64 
PP7 427 516,556,594,653 673, 724(sh) 246, 297 0.014 5.63 
PP9 429 558, 598,652 608, 655(sh) 179, 226 0.164 5.45 
  a -2 drops of TFA added to solution 


















TPP 416 505,547 646,708(sh) 230, 292 0.11 - 
PP1 420 511,547,588,643 652,707(sh) 232, 287 0.030 5.64 
PP2 425 515,553,590,649 670, 716(sh) 245, 291 0.010 5.59 
PP3 421 512,547,586,643 653, 712(sh) 232, 291 0.044 5.47 
PP4 424
 
514,552,588,648 663, 710(sh) 239, 286 0.015 5.36 




516,558,593,650 672 246 0.025 5.53 
PP7 426 515,555,591,650 671, 723(sh) 245, 297 0.015 5.50 
PP9 430 560, 598,645 616, 661(sh) 186, 231 0.029 5.35 




Figure 2-6: UV-Vis Absorption Spectra for PP1 (red), PP2 (green), PP3 (blue), PP4 (purple), 
PP5 (maroon), PP6 (pink), PP7 (yellow), and PP9 (brown) at 6μ  concentration in DMF 
 
 
Figure 2-7: Emission Spectra for PP1 (red), PP2 (green), PP3 (blue), PP4 (purple), PP5 





Figure 2-8: UV-Vis Absorption Spectra for ZnPP1 (red), ZnPP2 (green), ZnPP3 (blue), 




Figure 2-9: Emission Spectra for ZnPP1 (red), ZnPP2 (green), ZnPP3 (blue), ZnPP4 (purple), 




Figure 2-10: UV-Vis Absorption Spectra for ZnPP1 (red), ZnPP2 (green), ZnPP3 (blue), 
ZnPP4 (purple), ZnPP5 (maroon), ZnPP6 (pink), and ZnPP7 (yellow) at 4μ  concentration in 
DMF. 
 
Figure 2-11: Emission Spectra for ZnPP1 (red), ZnPP2 (green), ZnPP3 (blue), ZnPP4 





















ZnPP1 428 551,596 613,657 185, 229 0.02 5.3 
ZnPP2 426 548 604,648 178, 222 0.04 5.5 
ZnPP3 426 547 602,649 176, 223 0.03 5.5 
ZnPP4 428 551 608,656 180, 228 0.02 4.6 
ZnPP5 430 552 609,653 179, 223 0.001 5.7 
ZnPP6 432 554 621,657 189, 225 0.01 4.6 
ZnPP7 431 557 618,658 187, 227 0.02 5.6 
 

















ZnPP1 428 560, 603 618,664 190, 236 0.01 5.5 
ZnPP2 428 558, 599 609,658 181, 230 0.02 5.2 
ZnPP3 429 557, 598 609,659 180, 230 0.02 5.6 
ZnPP4 430 559 616,664 186, 234 0.01 4.8 
ZnPP5 431 559, 603 615,661 184, 230 0.01 5.7 
ZnPP6 433 560, 604 624,662 191, 229 0.05 4.7 






Figure 2-12: UV-Vis Absorption Spectra for CuPP1 (red), CuPP2 (green), CuPP3 (blue), 




Figure 2-13: UV-Vis Absorption for CuPP1 (red), CuPP2 (green), CuPP3 (blue), CuPP4 
(purple), CuPP5 (maroon), CuPP6 (pink), and CuPP7  yellow) at 4μ  concentration in D F. 
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Table 2-9: Photophysical Data for CuPPs in Toluene 





CuPP1 423 537 5.2 
CuPP2 418 533 5.5 
CuPP3 419 532 5.5 
CuPP4 421 534 4.5 
CuPP5 422 537 5.0 
CuPP6 426 538 4.6 
CuPP7 424 537 5.0 
 
Table 2-10: Photophysical Data for CuPPs in DMF 





CuPP1 422 537 5.5 
CuPP2 416 533 5.6 
CuPP3 418 533 5.9 
CuPP4 420 535 4.7 
CuPP5 422 538 4.9 
CuPP6 425 539 4.8 
CuPP7 424 540 5.2 
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The UV-Vis data of PP12 and PP13 unfortunately showed aggregation of the porphyrins. 
Addition of 2 drops of TFA to the solution containing the free bases did not change the outcome. 
Different solvents, including Toluene, DMF, DCM, CHCl3 were used, but unfortunately there 
still was aggregation as seen in figure 2-12 and 2-13.  
 
Figure 2-14: UV-Vis Spectra of PP14  at 0.24M (red), 0.25M(green), and 0.26M (blue)M in 
Toluene 
 
Figure 2-15: UV-Vis spectrum of PP14 0.24M (red), 0.25M (green), and 0.26 (blue)M in 
Toluene with 2 drops of TFA added to solution. 
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2.7 Biological Studies 
Porphyrins PP1-9 and ZnPP3 were all submitted for biological studies, which were performed 
by Dr. Xiaoke Hu. The in vitro studies were carried out on the porphyrins using human 
carcinoma HEp2 cells for the assays. With the exception of PP8, which recorded an IC50 value 
of  380 μ , all the porphyrins showed no dark toxicities  see Figure 2-12). When exposed to low 
light dose (1 J/ cm), they all showed no phototoxicity( see Figure 2-13). At a concentration of 
10μ , all porphyrins accumulated within the cells over time, with PP4 being taken up slightly 
more than the other porphyrins (see Figure 2-14). 
 
Figure 2-16: Dark Toxicities of porphyrins PP1(red), PP2(green), PP3(blue), PP4 (purple), PP5 
(maroon), PP6 (pink), PP7 (yellow), PP9 (brown) and ZnPP3 (light blue) toward HEp2 cells 
using Cell Titer Blue assay. 
 
To determine the efficiency of tumor destruction, the subcellular localizations of porphyrins 
PP1-9 and ZnPP3 in HEp2 cells were studied. The compounds were allowed to incubate 
overnight at concentrations of 10μ , after which they were evaluated by fluorescence 
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microscopy. The tracers used were BODIPY Ceramide (golgi), LysoSensor Green (lysosomes), 
Mitotracker Green (mitochondria), and ER-tracker Green (ER). 
 
Figure 2-17: Phototoxicities of porphyrins PP1 (red), PP2 (green), PP3 (blue), PP4 (purple), 
PP5 (maroon), PP6 (pink), PP7 (yellow) and PP9 (brown) and ZnPP3 (light blue) toward HEp2 
cells at 1 J/cm light dose using the Cell Titer Blue assay. 
 
 
Figure 2-18: Time-dependent uptake of porphyrins PP1 (red), PP2 (green), PP3 (blue), PP4 
(purple), PP5 (maroon), PP6 (pink), PP7 (yellow), PP9 (brown) and ZnPP3 (light blue) at 




In all the micrographs, (a) shows the phase contrast (b) shows the overlay of phase contrast with 
fluorescence of the compound, (c) shows fluorescence of ER-Tracker green, (d) shows the 
fluorescence of ER-tracker green and the compound (e) shows the fluorescence of MitoTracker 
Green (f) shows the overlay of the fluorescence of MitoTracker Green and the compound (g) 
shows the fluorescence of LysoSensor Green (h) shows the overlay of the fluorescence of 
LysoSensor Green and the compound (i) shows the fluorescence of BODIPY Ceramide, (j) 
shows the overlay of the fluorescence of BODIPY Ceramide and the compound. To our pleasant 
surprise, all compounds showed localization in mitochondria. This is a remarkable discovery, 
because mitochondria is considered the “powerhouse” of the human cell. Therefore, destroying 
of the cells will be more effective if the photosensitizer is located within the mitochondria. 
 
       PP1                                       PP2 
Figure 2-19 Subcellular localization of PP1 and PP2 in HEp2 cells at 10μ  for 24 h.  a) Phase 
contrast, (b) overlay of PP1 and PP2 and phase contrast, (c) ER-tracker green fluorescence (e) 
MitoTracker Green Fluorescence (g) LysoSensor Green fluorescence, (i) BODIPY Ceramide 




           PP3                                  PP4 
Figure 2-20: Subcellular localization of PP3 and PP4 in HEp2 cells at 10μ  for 24 h.  a) Phase 
contrast, (b) overlay of PP3 and PP4 and phase contrast, (c) ER-tracker green fluorescence (e) 
MitoTracker Green Fluorescence (g) LysoSensor Green fluorescence, (i) BODIPY Ceramide 
fluorescence, (d), (f), (j) overlays of organelle tracers with PP3 and PP4. Scale bar: 10 μ . 
 
          PP5                                    PP6 
Figure 2-21: Subcellular localization of PP5 and PP6 in HEp2 cells at 10μ  for 24 h.  a) Phase 
contrast, (b) overlay of PP5 and PP6 and phase contrast, (c) ER-tracker green fluorescence (e) 
MitoTracker Green Fluorescence (g) LysoSensor Green fluorescence, (i) BODIPY Ceramide 




          PP7                                  PP9 
Figure 2-22: Subcellular localization of PP7 and PP9 in HEp2 cells at 10μ  for 24 h.  a) Phase 
contrast, (b) overlay of PP7 and PP9 and phase contrast, (c) ER-tracker green fluorescence (e) 
MitoTracker Green Fluorescence (g) LysoSensor Green fluorescence, (i) BODIPY Ceramide 
fluorescence, (d), (f), (j) overlays of organelle tracers with PP7 and PP9. Scale bar: 10 μ . 
 
Figure 2-23: Figure 3-18: Subcellular localization of ZnPP3 in HEp2 cells at 10μ  for 24 h.  a) 
Phase contrast, (b) overlay of ZnPP3 and phase contrast, (c) ER-tracker green fluorescence (e) 
MitoTracker Green Fluorescence (g) LysoSensor Green fluorescence, (i) BODIPY Ceramide 
fluorescence, (d), (f), (j) overlays of organelle tracers with ZnPP3. Scale bar: 10 μ . 
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Table 2-11: A summary of the porphyrins PP1-9 and ZnPP3 localizations. 
Compound Localization Partial Localization 
PP1 Mitochondria, Golgi Lysosome 
PP2 Mitochondria Golgi, Lysosome, ER 
PP3 Mitochondria Lysosome 
PP4 Mitochondria Golgi, Lysosome 
PP5 Mitochondria, Golgi Lysosome 
PP6 Mitochondria, Golgi Lysosome, ER 
PP7 Mitochondria, Golgi Lysosome, ER 
PP9 Mitochondria, Golgi Lysosome, ER 
ZnPP3 Mitochondria Lysosome, Golgi 
 
2.8 Conclusions 
The MacDonald [2+2] condensation was successfully used to synthesize a total of thirteen 
thienyl-substituted porphyrins. In all cases, silica gel chromatography was used to purify the 
products using mixtures of EtOAc/Hexane for elution. The photophysical data obtained showed 
that the porphyrins were indeed potential candidates for PDT and BNCT. This was further 
supported by the biological studies, which showed that all of them localized in various cell 
organelles, including mitochondria, lysosome, golgi and the ER. Further work which entails 




All reactions were monitored by thin layer chromatography (TLC) using 0.25mm silica gel plates 
purchased from Sorbent technologies, with or without UV indicator (60F-254). All column 
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NMR spectra were obtained either on a DPX-250 or AV-400 Bruker spectrometer. Chemical 









C). MALDI-TOF mass spectra were obtained on a Bruker OmniFLEX 
MALDI-TOF mass spectrometer. ESI-TOF was obtained on Agilent 6210. Decarborane and 1-
methyl-o-carborane were obtained from Katchem, Inc. (Czech Republic), while the other 
reagents and solvents were obtained from either Sigma-Aldrich or Fischer Scientific, and were 
used without further purification. 
Cell Culture 
All tissue culture media and reagents were obtained from Invitrogen. HEp2 cells were plated on 
LabTek II two chamber coverslips. They were allowed to grow for a duration of 24-48h. 
Compounds being investigated were then added at 10μ  and incubated overnight. This was then 
followed by the addition of the tracers, which were added concurrently with the compound for 
the remainder of the incubation period. The tracers used were: BODIPY Ceramide, ERTracker 
Green, LysoSensor Green and MitoTracker Green. Distribution of the compound was determined 
using a Zeiss AxioVert 200M inverted fluorescent microscope fitted with standard texas Red, 
FITC, DAPI and Cy5LP filter sets. 
Phototoxicity 
The HEp2 cells were placed at 7500 per well in costar 96-well plate and allowed to grow 
overnight. Compounds were diluted to 100μ  in medium, and then diluted to the final working 
concentrations of 6.25μ .  If D SO was required to dissolve the compound, a 1% D SO 
concentration was maintained throughout the experiment and dilutions by replacing the growth 
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medium with medium plus 1% DMSO before making dilutions) The cells were then incubated 
overnight (20-24h). The loading medium was then removed and the cells were fed medium 
containing 50m  HEPES pH 7.4. The plate was placed on ice. It was then exposed to a 610nm 
LP filtered light from a halogen lamp for 20 minutes   1 Jcm
-2
). IR radiation was filtered using a 
10nm water layer contained in a petri dish placed on top of the 96 well plate. The medium was 
removed and cells fed medium containing 20μL CellTiter Blue per 100μL medium and then 
incubated for 4 hours. This was followed by conversion of the substrate by viable cells which 
was measured by fluorescence. 
Dark Toxicity 
HEp2 cells were plated at 7500 cells per well in Costar 96-well plates and allowed to grow for 
48h. Compounds were diluted to 100μ  in medium, and then diluted to 6.5μ .  If D SO was 
required to dissolve the compound, a 1% DMSO concentration was maintained throughout the 
experiment and dilutions by replacing the growth medium with medium plus 1% DMSO before 
making dilutions) The cells were incubated overnight (20-24h). Loading medium was then 
removed and cells were fed medium containing 20μL CellTiter Blue per 100μL medium and 
then incubated for 4h. This was followed by conversion of the substrate by viable cells which 
was measured by fluorescence at 570/615nm. 
Time Dependent Cellular Uptake 
HEp2 cells were plated at 7500 per well on Costar 96-well dish and allowed to grow for 48h. 
Compounds were diluted to a 20μ  stock in medium. Equal volume of the stock was added in 
triplicate wells containing cells  100μL) to give a final concentration of 10μ . The cells were 
exposed to the compounds for 1h, 2h, 4h, 8h and 24h. At the end of the incubation time, the 
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medium was removed and the cells washed with 200μL of PBS. After removal of PBS, the cells 
and compounds were then solubilized using 100μL of 0.25% Triton X-100 in PNS. To determine 
the compound concentration, fluorescence emission was read using FLUOstar plate reader using 
excitation/emission wavelengths appropriate for the compound under study. The cell numbers 
were quantified using the CyQuant cell proliferation assay reagent. 
Fluorescence Measurements 
All experiments were performed at room temperature, in toluene and DMF. In some cases, a 
drop of TFA was added to the dilute solutions to prevent aggregation. UV-Vis absorbance was 
measured using a Perkin Elmer Lambda 35 UV-Vis Spectrometer. Fluorescence measurements 
were taken on a Fluorolog
®
-HORIBA JOBINVYON, Model LFI-3751 Spectrofluorimeter. 
Fluorescence quantum yields  Фf) were calculated by using the following equation: 
 
Where [F(sample)] and [F(standard)] are the integrated emission areas of the porphyrins and the 
standard respectively. [A(standard)] and [A(sample)] are the optical densities of the standard and 
the porphyrins, respectively, at the excitation wavelengths. Free base, TPP  Фf = 0.11) was used 
as the standard for free base porphyrins, and the Zn-complexed derivative, ZnTPP  Фf = 0.033) 
was used as the standard for ZnPPs. 
General Procedure for Metal Insertion 
Starting material was dissolved in DCM/MeOH (3:1) and excess amount of  
Zn(OAc)2/Cu(OAc)2 added. For Zn-porphyrin complexes, the reaction mixture was stirred at 
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room temperature for 24 hours. For Cu-porphyrin complexes, the reaction mixtures were stirred 
at room temperature for 12 hours and then refluxed for 4 h. The resulting mixtures were dried 
under vacuum and purified using column chromatography using DCM as eluent to afford the 
final products. 
Synthesis of DP-1 
2-Thiophene carboxaldehyde (1.0g, 8.9 mmol) was added to freshly distilled pyrrole (25.7g, 
382.7mmol) in a round bottom flask, under nitrogen. To this mixture was added TFA (0.1g, 0.89 
mmol) and the mixture allowed to stir for 30 minutes at room temperature. The mixture was 
poured in water (50 mL) and extracted with DCM (3 x 50mL). The organic layer was washed 
with saturated NaHCO3 (3 x 50 mL), followed by water (3 x 50 mL). The organic layers were 
dried over Na2SO4 and dried under vacuum. Crude product was purified by column 
chromatography using 1:5 EtOAc:Hexane to obtain 1.3g of the title compound as 64% yield. 
1
H 
NMR (CDCl3, 400 Hz) δ 7.83  2H, bs s), 7.11  1H, dd, J = 4 Hz, J= 1.2Hz), 6.86 (1H, m), 6.78 
(1H, m), 6.58 (2H, d, J= 4Hz), 6.07 (2H, d, J= 4Hz), 5.94 (2H, br s), 5.62 (1H, S). 
13
C NMR 
(CDCl3, 100MHz) 145.8, 132.1, 126.9, 125.7, 124.7, 117.5, 108.6, 107.2, 39.2. ESI-TOF m/z 
calcd for C13H10N2S 228.07, found 228.06 m.p. 117-118
o
C. 
Synthesis of PP1 
A solution of DP-1 (0.04g, 0.177mmol) and 2-thiophene-carboxaldehyde (0.0198g, 0.177mmol) 
in 18 mL DCM was purged with argon for 15 minutes. BF3.OEt2 (0.0022g, 0.018mmol) in 18 
mL DCM was also purged with argon for 15 minutes. The BF3.OEt2 solution was then added to 
the solution containing the dipyrromethane and the aldehyde, and the mixture stirred at room 
temperature for 2h. The reaction was monitored by TLC. After TLC confirmed no starting 
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material present, DDQ(0.06g, 0.266mmol) was added to the reaction flask and the reaction 
mixture stirred for 30 minutes. The reaction mixture was then filtered through a pad of silica gel, 
and the filtrate dried under vacuum. The product was purified using column chromatography, 
using 1:5 EtOAc:Hexane to afford 0.043g of the title compound as 56% yield.
1
H NMR (CDCl3, 
250 Hz) δ 9.04  8H, s), 7.91  4H, d, J= 3.4Hz), 7.85 (4H, d, J=3.4Hz), 7.50 (4H, m). ZnPP1 
obtained in 54% yield MALDI-TOF m/z calcd for C36N20N4S4Zn, 699.99, found 699.99. CuPP1 
obtained in 71% yield MALDI-TOF m/z calcd for C36N20N4CuS4, 698.99, found 698.99. 
Synthesis of PP2 
A solution of DP-1 (0.04g, 0.177mmol) and benzaldehyde (0.019g, 0.177mmol) in 18 mL DCM 
was purged with argon for 15 minutes. BF3.OEt2 (0.0022g, 0.018mmol) in 18 mL DCM was also 
purged with argon for 15 minutes. The BF3.OEt2 solution was then added to the solution 
containing the dipyrromethane and the aldehyde, and the mixture stirred at room temperature for 
2h. The reaction was monitored by TLC. After TLC confirmed no starting material present, 
DDQ(0.06g, 0.266mmol) was added to the reaction flask and the reaction mixture stirred for 30 
minutes. The reaction mixture was then filtered through a pad of silica gel, and the filtrate dried 
under vacuum. The product was purified using column chromatography, using 1:5 
EtOAc:Hexane to afford 0.048 g of the title compound as 44% yield. 
1
H NMR (CDCl3, 250MHz 
) δ 9.06  4H, d, J= 4Hz), 8.85 (4H, m), 8.23 (4H, m), 7.94 (2H, m), 7.87 (2H, m), 7.79 (6H, m), 
7.52 (2H, m). 
13
C NMR (acetone-d6, 100MHz) 137.6, 134.3, 133.2, 131.5, 128.9, 128.1, 127.5, 
126.5, 126.0, 125.2. ZnPP2 obtained in 98% yield. MALDI-TOF m/z calcd for.C40H24N4S2Zn, 
688.07, found 688.06. CuPP2 obtained in 94% MALDI-TOF m/z calcd for C40H24CuN4S2, 
687.07, found 687.089. 
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Synthesis of PP3 
A solution of DP-1 (0.02g, 0.088mmol) and 3,5-ditertbutyl benzaldehyde (0.019g, 0.088mmol) 
in 9 mL DCM was purged with argon for 15 minutes. BF3.OEt2 (0.0012g, 0.0088mmol) in 9 mL 
DCM was also purged with argon for 15 minutes. The BF3.OEt2 solution was then added to the 
solution containing the dipyrromethane and the aldehyde, and the mixture stirred at room 
temperature for 2h. The reaction was monitored by TLC. After TLC confirmed no starting 
material present, DDQ(0.03g, 0.131mmol) was added to the reaction flask and the reaction 
mixture stirred for 30 minutes. The reaction mixture was then filtered through a pad of silica gel, 
and the filtrate dried under vacuum. The product was purified using column chromatography, 
using 1:5 EtOAc:Hexane to afford 0.02 g of the title compound as 27% yield. 
1
H NMR (CDCl3, 
400 Hz) δ 9.06  4H, m), 8.90  4H, m), 8.14  4H, m), 8.03  2H, s), 8.00  2H, d, J= 3Hz), 7.96 
(2H, s), 7.56 (2H, m), 1.53 (36H, s). 
13
C NMR (acetone-d6, 100MHz) 149.0, 140.9, 133.9, 129.4, 
128.1, 126.2, 121.5, 34.8, 31.1. HRMS(ESI) m/z calcd for C56H58N4S2, 851.4175, found 
851.4193. ZnPP3 obtained in 53% yield. MALDI-TOF m/z calcd for C56H56N4S2Zn, 914.58, 
found 914.33. CuPP3 obtained in 21% yield. MALDI-TOF m/z calcd for C56H56CuN4S2, 911.32, 
found 911.21. 
Synthesis of PP4 
Procedure used was the same as that for PP1. Reagents used were, DP-1 (0.02g, 0.088mmol) and 
3,5-methoxy benzaldehyde (0.015g, 0.088mmol), BF3.OEt2 (0.0012g, 0.0088mmol), and 
DDQ(0.03g, 0.131mmol). The product was purified using column chromatography, using 1:5 
EtOAc:Hexane to afford 0.013 g of the title compound as 20% yield.
1
H NMR (CDCl3, 400MHz) 
δ 9.04  4H, m), 8.93  4H, m), 7.93  2H. d, J= 4Hz), 7.86 (2H, d, J= 4Hz), 7.51 (2H, m), 7.40 
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(4H, s), 6.91 (2H, s), 3.97 (12H, s). HRMS(ESI) calcd for C44H34N4O4S2, 747.2094, found 
747.2121. ZnPP4 obtained in 41% yield. MALDI-TOF m/z Calcd for C44H32N4O4S2Zn, 808.12, 
found 808.17. 
Synthesis of 5-bromothiophene-2-carbaldehyde (1) 
Thiophene-2-carbaldehyde (1.0g, 8.92 mmol) and NaHCO3 (0.82g, 9.81 mmol) were dissolved 
in dry CHCl3 (40 mL). The temperature was lowered to 0
o
C. The mixture was allowed to stir for 
30 minutes. Bromine (1.43g, 8.92 mmol) was then added dropwise while stirring, and the 
reaction allowed to warm to room temperature. The reaction mixture was stirred at this 
temperature for 3 h. It was then poured into water. The organic layer was washed with saturated 
NaHCO3 (2 x 20 mL), then water (3 x 20 mL) and the organic layers combined and dried over 
Na2SO4. The product was then dried under vacuum, and purified by column chromatography 
using 1:5 EtOAc:Hexane.
1
H NMR (CDCl3, 400MHz) 9.78 (1H, s), 7.53 (1H, d, J= 4Hz), 7.20 
(1H, d, J= 4Hz).  
Synthesis of DP-2 
 5-Bromothiophene-2-carbaldehyde (1) (1.0g, 5.23 mmol) was added to freshly distilled pyrrole 
(15.1g, 224.89 mmol) in a round bottom flask, under nitrogen. To this mixture was added TFA 
(0.06g, 0.523 mmol) and the mixture allowed to stir for 30 minutes at room temperature. The 
mixture was poured in water (50 mL) and extracted with DCM (3 x 50mL). The organic layer 
was washed with saturated NaHCO3 (3 x 50 mL), followed by water (3 x 50 mL). The organic 
layers were dried over Na2SO4 and dried under vacuum. Crude product was purified by column 
chromatography using 1:5 EtOAc:Hexane to obtain the title compound in 55 % yield. 
1
H NMR 
(CDCl3, 400 Hz) δ 9.81  2H, br s), 6.94  1H, d, J= 4Hz), 6.70 (2H, d, J= 1.6Hz), 6.59 (1H, dd, 
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J=2, J= 2 Hz), 6.00 (2H, m), 5.90 (2H, m), 5.67 (1H, s). 
13
C NMR (CDCl3, 100MHz) 147.4, 
129.5, 126.7, 125.8, 117.7, 108.6, 107.3, 39.5. 
Synthesis of PP5 
 Procedure used was the same as that for PP1. Reagents used were, DP-2 (0.02g, 0.065mmol) 
and 3,5-ditertbutyl benzaldehyde (0.014g, 0.065mmol), BF3.OEt2 (0.0001g, 0.0065mmol), and 
DDQ(0.022g, 0.0975 mmol). The product was purified using column chromatography, using 1:5 
EtOAc:Hexane to afford 0.013 g of the title compound as 20% yield. 
1
H NMR (CDCl3, 
400 Hz) δ 9.10  6H, m), 8.89  4H, m), 8.07  4H, m), 7.72  3H, m), 7.67  3H, m), 7.49  4H, m), 
1.53 (36H, s). 
13
C NMR (CDCl3, 100MHz). 161.2, 161.4, 143.2, 137.6, 129.1, 128.3, 127.2, 
125.4,105.3, 117.7, 31.1, 20.5.  ESI-TOF calcd for C56H56Br2N4S2, 1009.01, found 1009.2329. 
ZnPP5 obtained in 62% yield. MALDI-TOF m/z calcd for C56H54Br2N4S2Zn 1072.37, found 
1072.138. CuPP5 obtained in 59% yield. MALDI-TOF m/z calcd for C56H54Br2CuN4S2 1069.14, 
found 1069.12. 
Synthesis of PP6 
Procedure used was the same as that for PP1. Reagents used were, DP-1 (0.1g, 0.44mmol) and 
methyl 5-formyl-1H-pyrrole-2-carboxylate (0.067g, 0.44mmol), BF3.OEt2 (0.0062g, 
0.044mmol), and DDQ(0.15g, 0.655 mmol). The product was purified using column 
chromatography, using 1:3 EtOAc:Hexane to afford 0.067 g of the title compound as 21% yield. 
1
H NMR (CDCl3, 400 Hz) δ 9.07  6H, m), 7.94  2H, m), 7.88  2H, m), 7.53  4H, m), 7.29  4H, 
s), 1.55 (6H, s). MALDI-TOF calcd for C40H28N6O4S2, 720.82, found 720.137. ZnPP6 obtained 




Synthesis of PP7 
Procedure used was the same as that for PP1. Reagents used were, DP-1 (0.1g, 0.44mmol) and 
5-(4-methoxybenzoyl)-1H-pyrrole-2-carbaldehyde (0.089g, 0.44mmol), BF3.OEt2 (0.0062g, 
0.044mmol), and DDQ(0.15g, 0.655 mmol). The product was purified using column 
chromatography, using 1:3 EtOAc:Hexane to afford the title compound in 18% yield. 
1
H NMR 
(acetone-d6, 400 Hz) δ 9.17  4H, br s), 9.10  4H, m), 8.11 4H, d, J= 5Hz), 8.04 (4H, m), 7.26 
(4H, m), 7.43 (1H, m), 7.36 (1H, m), 7.05 (4H, m), 3.91 (6H, s). ZnPP7 obtained in 72% yield. 
13
C NMR (acetone-d6, 100MHz) 151.1, 143.6, 133.4, 131.8, 131.7, 128.9, 128.1, 127.6, 126.0, 
125.2, 114.9, 50.6, 20.5. MALDI-TOF m/z calcd for C52H34N6O4S2Zn 936.37, found 936.15. 
Synthesis of Compound 2 
To a solution of Cs[3,3‟-Co(1,2-C2B9H11)2] (1.0g, 2.2 mmol) in anhydrous 1,4-dioxane (100 mL) 
was added BF3.OEt2 (2.49g, 17.52 mmol) and the reaction mixture heated at reflux under N2 
atmosphere for 5h. The reaction mixture was allowed to cool temperature. It was then filtered, 
and the filtrate dried under vacuum. The product was purified by column chromatography using 
30% DCM/Hexane, followed by 100% DCM to obtain the title compound. Yield 72%. 
1
H NMR 
data correlates to literature data. 
Synthesis of PP8 
 BBr3 (0.2g, 0.81 mmol) was dissolved in DCM (0.5 mL) and the solution temperature lowered 
to -20
o
C. Under N2 atmosphere, a solution of PP4 (0.02g, 0.027 mmol) in DCM (1 mL) was 
added to the BBr3 solution slowly with stirring, over 15 minutes. The reaction mixture was then 
allowed to warm up to room temperature, and allowed to stir for 24h. It was then poured into 
water, followed by extraction with EtOAc. The organic layer was washed with brine, then 
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saturated NaHCO3 solution. The organic layers were then dried over Na2SO4, filtered and dried 
under vacuum to give the title product. Yield, 0.0162g,  87% 
1
H NMR (acetone-d6, 400 Hz) δ 
9.01 (8H, br s), 8.67 (4H, m), 8.02 (4H, m), 7.54 (2H, m), 7.20 (4H, s), 6.80 (2H, t).  
Synthesis of PP9 
In a round bottom flask, PP8 (0.0162g, 0.023 mmol) and K2CO3 (0.025g, 0.184 mmol) were 
dissolved in 15 mL acetone. The reaction mixture was allowed to stir at room temperature and 
compound 2 (0.037g, 0.092 mmol) added in one portion. The reaction mixture was allowed to 
stir at room temperature for 2h. This was followed by  reflux for 24h, after which it was allowed 
to cool to room temperature and a second portion of compound 2 (0.018g, 0.046 mmol) was 
added. The reaction mixture was then refluxed for 24 h. After this period, it was cooled to room 
temperature and a third portion of compound 2 (0.018, 0.046 mmol) added, followed by reflux 
for 24 h. After cooling it to room temperature, the reaction mixture was dried under vacuum. The 
product was purified by column chromatography using 1:1 EtOAc: Hexane to afford 60% yield. 
1
H NMR (acetone-d6, 250 Hz) δ 8.98  6H, m), 7.94  2H, d, J= 4Hz), 7.86 (2H, d, J= 4Hz), 7.51 
(4H, m), 7.13 (4H, m), 6.73 (2H, s), 5.13 (8H, m), 2.73 (8H, m), 2.21 (8H, m), 2.18 (8H, m), 1.8-
0.5 (72H, br, BH). 
Synthesis of Compound 3 
3,5-Dimethylbromobenzene (0.1g, 0.54 mmol) was dissolved in dry CCl4 (7 mL). Under argon, 
NBS (0.21g, 1.19 mmol) was added and benzoyl peroxide (0.02g, 0.07 mmol) added to the 
reaction mixture in portions over 1 hr period. The final reaction mixture was refluxed with 
stirring for 16 h. It was then allowed to cool to room temperature, after which it was filtered and 
the filtrate washed with saturated NaHCO3 and once with water. The organic layer was dried 
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over Na2SO4 and dried under vacuum. The resulting residue was purified by column 
chromatography using DCM/PET ether 1/9 as eluant. 
1
H NMR (CDCl3, 400MHz) 7.62 (2H, d, 
J= 4Hz), 7.49 (1H, s), 4.55 (4H, s).  
Synthesis of Compound 4 
1-Methyl-o-carborane (0.202g, 1.276 mmol) was dissolved in dry THF (13 mL) and temperature 
kept between -5 and 0
o
C. n-BuLi (2.5M/Hexane)  (0.49ml, 1.22 mmol) was added dropwise to 
the solution under argon. The mixture was stirred at this temperature range for 1.5h, and 
temperature lowered between between -15
o
C and - 20
o
C. A solution of LiI (0.02g, 0.18 mmol) in 
dry THF (1.7 mL) and 1-bromo-3,5-bis(bromomethyl)benzene (0.2g, 0.58 mmol) in  THF (3 
mL) were added to the reaction mixture, and the final mixture allowed to warm to room 
temperature and stirred for 16h at this temperature. The reaction was quenched with water, and 
the resulting mixture extracted with diethyl ether (3 x 10 mL). The organic layers were combined 
and washed with water, and brine. The organic layer was then dried over Na2SO4, and dried 
under vacuum. Product was purified using column chromatography using DCM/PET ether 1/4. 
1
H NMR (CDCl3, 400 Hz) δ 7.48  2H, s), 7.32  1H, s), 4.41  4H, s), 3.42  6H, s), 2.9-1.5(20H, 
br, BH).  
Synthesis of Compound 5  
Dicarboranylbromobenzene (0.286g, 0.57 mmol) was dissolved in THF (6 mL) and the solution 
put under argon. It was then cooled to -78
o
C and nBuLi (2.5M/Hexane) (0.26 ml, 0.64 mmol) 
was added dropwise via syringe. After stirring the reaction mixture for 30 minutes at this 
temperature, dry DMF (0.21g, 2.85 mmol) was slowly added. The resulting mixture was stirred 
at -78
o
C for 30 minutes and then warmed up to 0
o
C and stirred for 1h at this temperature. A 5% 
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aqueous HCl solution was added until the pH of the reaction mixture was between 2 and 3. The 
final mixture was stirred at room temperature for 15 minutes. The aqueous layer was extracted 
with diethyl ether, and the organic fraction dried over anhydrous MgSO4 and the solvent 
evaporated under vacuum. The product was purified by column chromatography using 
DCM/PET ether 2/3 to obtain 50% of title compound. 
1
H NMR (CDCl3, 400 Hz) δ 9.98  1H, 
s), 7.62 (2H, d, J = 1.5Hz), 7.28 (1H, d, J = 1.5Hz), 3.52 (4H, s), 2.18 (6H, s), 1.3-3.2 (20H, br) 
Synthesis of PP10 
Procedure used was the same as that for PP1. Reagents used were, DP-1 (0.02g, 0.088mmol), 
compound 6 (0.04g, 0.088mmol), BF3.OEt2 (0.0012g, 0.0088mmol), and DDQ (0.003g, 
0.0132mmol). Product was purified using silica gel chromatography using 1:3 EtOAc/Hexane to 
give 0.007g,  6% of the title compound. 
1
H NMR (CDCl3, 400 Hz) δ 9.00  4H, m), 8.93  4H, 
m), 8.07 (4H, m), 8.02 (2H, s), 7.98 (2H, m), 7.96 (2H, s), 7.54 (2H, m), 3.92 (s, 8H), 2.33 (s, 
12H), 1.2-3.3 (br, 40H).  
Synthesis of Compound 7 
5-Bromothiophene-2-carbaldehyde (1.674g, 8.765 mmol), PdCl2(PPh3)2 (0.154g, 0.219 mmol), 
and CuI(0.0834g, 0.438 mmol) were dissolved in THF (30 mL). TMSA (0.947g, 9.64 mmol) was 
added to the reaction mixture under argon and Et3N (36 mL) added to the reaction mixture. The 
reaction was allowed to stir at room temperature for 24 h. The reaction mixture was then poured 
into water, and extracted with EtOAc. Product was purified using 1:5 EtOAc/Hexane 
1
HNMR 




Synthesis of DP-4 
 5-((trimethylsilyl)ethynyl)thiophene-2-carbaldehyde  (0.3g, 1.44mmol) was added to freshly 
distilled pyrrole (1.93g 28.80 mmol) in a round bottom flask, under nitrogen. To this mixture 
was added TFA (0.033g, 0.288 mmol) and the mixture allowed to stir for 30 minutes at room 
temperature. The mixture was poured in water (5 mL) and extracted with DCM (3 x 5mL). The 
organic layer was washed with saturated NaHCO3 (3 x 5 mL), followed by water (3 x 5 mL). The 
organic layers were dried over Na2SO4 and dried under vacuum. Crude product was purified by 
column chromatography using 1:3 EtOAc:Hexane to obtain the title compound in 54 % yield. 
1
H 
NMR (CDCl3) δ 7.97  2H, br s), 7.09  1H, d, J=4Hz), 6.73 (3H, m), 6.17 (2H, d, J= 2.5Hz), 6.05 
(2H, s), 5.68 (1H, s), 0.23 (9H, s).  
Synthesis of DP-3 
 Trimethylsilane protecting group was removed by reacting DP-4 (0.03g, 0.092 mmol) with 
K2CO3 (0.038g, 0.276mmol)  dissolved in a Hexane/MeOH mixture (8:2) (5 mL) at room 
temperature for 2h. The reaction was quenched by adding water. This was extracted with Et2O, 
and the organic layer dried over Na2SO4 and dried under vacuum. The title compound was 
obtained in 73% yield. 
1
H NMR (CDCl3, 400 Hz) δ 8.01  2H, br s), 7.13  1H, d, J= 4), 6.76 
(1H. d, J= 4), 6.72 (2H, d, J= 1.5 Hz), 6.18 (2H, dd, J= 4Hz), 6.06 (2H, s), 5.70 (1H, s), 3.3 (1H, 
s). ESI-TOF calcd for C15H12N2S, 252.33 found, 253.08. 
Synthesis of DP-5 
 Decarborane (0.15g, 0.60 mmol), DP-3 (0.15g, 1.20 mmol), dry CH3CN (1.5 mL) and dry 
toluene (4.5 mL) was mixed in a round bottom flask. The reaction was stirred under N2 at 80
o
C 
for 24h. After it was cooled to room temperature, MeOH (3.0 mL) was added to the reaction 
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flask and stirred for 30 minutes. The reaction mixture was dried under vacuum, and the product 
purified by column chromatography using 20% DCM/Hexane as eluent, to yield 34% of the title 
product. 1H NMR 7.93 (2H, br s), 7.63 (1H, s), 7.47 (1H, s), 6.93 (2H, m), 6.65 (3H, m), 6.07 
(1H, d, J= 4), 5.94 (1H, s), 1.8-0.5 (10H, br, BH).  
Synthesis of PP11 
Procedure used was the same as that for PP1. Reagents used were, DP-5 (0.006g, 0.016mmol) 
and 3,5-ditertbutyl benzaldehyde (0.004g, 0.0.016mmol), BF3.OEt2 (0.00023g, 0.0016 mmol), 
and DDQ(0.005g, 0.024 mmol). The product was purified using column chromatography, using 
1:5 EtOAc:Hexane to afford the title compound in 6% yield. 1H NMR (CDCl3, 400 Hz) δ 9.23 
(4H, m), 8.97 (4H, m), 7.91 (2H, d, J= 4Hz), 7.47 (2H, m), 7.87 (2H, d, J= 4Hz), 7.34 (4H, m), 
1.89 (s, 36H), 1.3-3-2 (br, 20H). MALDI-TOF m/z calcd for C60H78B20N4S2, 1134.76, found 
1134.97. 
Synthesis of Compound 9 
 [2,2'-Bithiophene]-5-carbaldehyde (2.0g, 10.29 mmol) was dissolved in CHCl3 (20 mL). The 
temperature was lowered to 0
o
C. Bromine (1.65g, 10.29 mmol) was added dropwise to the 
reaction flask, and the reaction mixture allowed to warm to room temperature. It was allowed to 
stir at this temperature for 2h. The reaction mixture was poured into 20 mL water. The organic 
layer was then washed with saturated NaHCO3 and dried over Na2SO4. The product was purified 
by column chromatography using 1:3 EtOAc/Hexane to obtain 2.5g of the target compound. 
1
H 
NMR (CDCl3, 250MHz) 9.86 (1H, s), 7.66 (1H, d, J= 4), 7.19 (1H, d, J= 4), 7.11 (1H, d, J= 4), 




Synthesis of Compound 13 
 5'-Bromo-[2,2'-bithiophene]-5-carbaldehyde (1.0g, 3.65 mmol), PdCl2(PPh3)2 (0.064g, 0.091 
mmol), and CuI(0.035g, 0.183 mmol) were dissolved in THF (40 mL). TMSA (0.39g, 4.0 mmol) 
was added to the reaction mixture under argon and Et3N (40 mL) added to the reaction mixture. 
The reaction was allowed to stir at room temperature for 24 h. The reaction mixture was then 
poured into water, and extracted with EtOAc. Product was purified with column 
chraomatography using 1:3 EtOAc/Hexane. 
1
H NMR (CDCl3, 400MHz) 
1
H NMR (CDCl3, 
400 Hz) δ 9.87  1H, s), 7.67  1H, d, J= 4Hz), 7.24 (1H, d, J= 4), 7.20 (1H, d, J=4), 7.17 (1H, d, 
J= 4), 0.26 (9H, s). 
Synthesis of DP-6 
 5'-((Trimethylsilyl)ethynyl)-[2,2'-bithiophene]-5-carbaldehyde  (0.124g, 0.43mmol) was added 
to freshly distilled pyrrole (0.57g, 8.55 mmol) in a round bottom flask, under nitrogen. To this 
mixture was added TFA (0.0097g, 0.086 mmol) and the mixture allowed to stir for 30 minutes at 
room temperature. The mixture was poured in water (2 mL) and extracted with DCM (3 x 2mL). 
The organic layer was washed with saturated NaHCO3 (3 x 2 mL), followed by water (3 x 2 mL). 
The organic layers were dried over Na2SO4 and dried under vacuum. Crude product was purified 
by column chromatography using 1:3 EtOAc:Hexane to obtain the title compound. 
1
H NMR 
(CDCl3, 400MHz) 8.04 (2H, br s), 7.18 (1H, m), 7.08 (1H, m), 6.94 (1H, m), 6.84 (1H, d, J= 4), 
6.80 (1H, d, J= 4), 6.73 (2H, s), 6.27 (1H, d, J= 1.8Hz), 6.19 (2H, d, J= 3Hz), 5.71(1H, s), 0.25 





Synthesis of DP-7 
 Trimethylsilane protecting group was removed by reacting DP-6 (0.12g, 0.30 mmol) with 
K2CO3 (0.12g, 0.89mmol)  dissolved in a Hexane/MeOH mixture (8:2) (20 mL) at room 
temperature for 2h. The reaction was quenched by adding water. This was extracted with Et2O, 
and the organic layer dried over Na2SO4 and dried under vacuum. 
1
H NMR (CDCl3, 400MHz) δ 
8.06 (2H, br s), 7.19 (1H, d, J= 4), 7.09 (1H, m), 6.99 (2H, m), 6.73 (3H, m), 6.19 (2H, d, J= 
2.8Hz), 6.09 (1H, s), 5.72 (1H, s), 3.34 (1H, s). ESI-TOF calcd for C19H14N2S2, 334.06, found 
334.05. 
Synthesis of DP-8 
 Decarborane (0.10g, 0.30 mmol), DP-7 (0.07g, 0.60 mmol), dry CH3CN (1.0 mL) and dry 
toluene (3.0 mL) was mixed in a round bottom flask. The reaction was stirred under N2 at 80
o
C 
for 24h. After it was cooled to room temperature, MeOH (2.0 mL) was added to the reaction 
flask and stirred for 30 minutes. The reaction mixture was dried under vacuum, and the product 
purified by column chromatography using 20% DCM/Hexane as eluent 
Synthesis of PP12 
Procedure used was the same as that for PP1. Reagents used were, DP-8 (0.010g, 0.022mmol) 
and 3,5-ditertbutyl benzaldehyde (0.005g, 0.022mmol), BF3.OEt2 (0.0003g, 0.0022mmol), and 
DDQ(0.008g, 0.033mmol). The product was purified using column chromatography, using 1:3 
EtOAc:Hexane to afford 0.002g of the title compound as 8% yield. 7.91 (4H, br s), 7.57 (2H, d, 




Synthesis of DP-9 
  2,2‟-Bithiophene)-5-carboxaldehyde (1.0g, 5.15 mmol) dissolved in minimal DCM was added 
to freshly distilled pyrrole (6.91g, 102.95 mmol) in a round bottom flask, under nitrogen. To this 
mixture was added TFA (0.04g, 0.515 mmol) and the mixture allowed to stir for 30 minutes at 
room temperature. The mixture was poured in water and washed with saturated NaHCO3. The 
organic layers were dried over Na2SO4 and dried under vacuum. Crude product was purified by 
column chromatography using 1:4 EtOAc:Hexane. 
1
H NMR (CDCl3, 250 Hz) δ 7.95  2H, br s), 
7.26 (1H, d, J= 4), 7.24 (1H, d, J= 4), 7.20 (2H, m), 6.73 (2H, m), 6.26 (2H, m), 6.04 (2H, s), 
5.70 (1H, s). 
Synthesis of PP13 
Procedure used was the same as that for PP1. Reagents used were, DP-9 (0.15g, 0.48mmol) and 
3,5-ditertbutyl benzaldehyde (0.105g, 0.48 mmol), BF3.OEt2 (0.0069g, 0.048 mmol), and 
DDQ(0.165g, 0.727 mmol). The product was purified using column chromatography, using 1:5 
EtOAc:Hexane to afford the title compound in 18% yield. 
1
H NMR (CDCl3, 400 Hz) δ 7.99 
(4H, br s), 7.69 (2H, d, J= 4Hz), 7.62 (2H, d, J=4Hz), 7.54 (4H, m), 7.33 (4H, m), 7.22 (4H, m), 
6.73 (4H, m), 1.96 (36H, s). ESI-TOF calcd for C64H62N4S4, 1015.46, found 1015.84. ZnPP13 
MALDI-TOF m/z calcd for C64H60N4S4Zn 1078.83, found 1078.085. 
Synthesis of PP14 
Procedure used was the same as that for PP1. Reagents used were, DP-9 (0.097g, 0.315mmol) 
and 3,5-dimethoxy benzaldehyde (0.052g, 0.315 mmol), BF3.OEt2 (0.0045g, 0.0315 mmol), and 
DDQ(0.143g, 0.629 mmol). The product was purified using column chromatography, using 1:5 
EtOAc:Hexane to afford the title compound in 21% yield. 
1
H NMR (CDCl3, 400 Hz) δ 7.89 
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(4H, br s), 7.52 (8H, m), 7.25 (8H, m), 6.09 (4H, m), 2.01 (12H, s). ESI-TOF calc for 
C52H38N4O4S4, 911.14, found 911.48. ZnPP14 MALDI-TOF m/z calcd for C52H36N4O4S4Zn 
972.09, found 972.069. CuPP14 MALDI-TOF m/z calcd for C52H36CuN4O4S4, 972.67, found 
973.22. 
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CHAPTER 3: CARBORANYL FUNCTIONALIZED THIOPHENES FOR 
ELECTROPOLYMERIZATION AND BNCT 
3.1 Introduction 
Since prehistoric time, polymers have been used by Man in the form of skin, wood, bone, and 
fibers. Today, synthetic polymers represent the most widely used material in our day to day life. 
The development of polymeric science dates back to the 20
th
 century, and since then, a lot of 
research has been carried out in this field. It is important to note that polymers were essentially 
designed to be insulators. We have materials such as plastics, rubber tubings, live wire plastic 
coatings, and anti-rusting materials. The list goes on and on. This was the case until 1976, when 
American scientists Heeger and MacDiarmid and their Japanese colleague Shirakawa discovered 
that when doped with iodine, polyacetylene developed metal-like properties with an increase in 
conductivity; this marked the beginning of modern development of conducting polymers
1
. Since 







 and  poly(phenylenevinylene)
5
(see examples in Figure 3-
1). 
 
Figure 3-1: Structures of poly(phenylenevinylene) 1 and polyaniline 2 
 
In our research, we are interested in one group of conducting polymers, heterocyclic conjugated 
polymers. These polymers can be viewed as sp
2
px chains whereby the structure similar to that of 
cis-(CH)x is stabilized by a heteroatom
6
 (Figure 3-2). Since their discovery, heterocyclic 
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Figure 3-2: Structure of cis-(CH)x and heterocyclic conjugated polymers stabilized by a 
heteratom 
 
3.2 Polythiophene Synthesis 
Polythiophenes in particular have attracted a lot of interest in the research world and they have 
fast become the most frequently used π-conjugated materials. The main reason for this is that 
thiophenes can be easily functionalized to make a wide range of compounds. They can also be 
used as building blocks to make π-conjugated systems using transition metal-catalyzed cross-
coupling reactions that are well developed. Another reason is that they have unique redox, 
optical and electronic properties, as well as the ability to self-assemble on solid surfaces
11
. There 
are two main routes by which polythiophenes (PTs) can be synthesized, i.e. the chemical route 
and the electrochemical route. Since their first synthesis in the 1980‟s, many PTs have been 
prepared by chemical synthesis. There has been a lot of interest in this field especially with the 
marked improvements in solubility of the PTs. The major drawback, however, is that polymers 
produced by this method contain significant regiochemical defects. This in turn leads to a loss of 
effective conjugation, and hence reduced conductivity levels. McCullough et al.
12
 and Rieke et 
al.
13 
have both designed syntheses that help overcome this problem (see Scheme 3-1). As a 
result, the polymers obtained have shown improved conductivity levels
6, 14
.  




Scheme 3-1: Two synthetic routes for preparing polythiophenes
14
 
The second type of polymer synthesis, electropolymerization, also helps overcome this problem 
of regio-irregularity. In 1979, it was shown that polypyrrole could be produced by 
electropolymerization of pyrrole
15











. Synthesis of 
polythiophenes via electropolymerization has proved to be a challenge due to the so called 
“polythiophene paradox”. This phenomenon refers to the overoxidation of polythiophenes 
whereby it competes with polymerization and oxidation of the monomer leading to the physical 
and chemical degradation of the polymer
20
. The mechanism of electrochemical formation of 
conducting polymers is characterized by the deposition of charged species produced by oxidation 








The control of structure and properties of PTs has been pursued through the modification of the 
monomer structure. This can be achieved by the use of oligothiophenes as the monomeric unit
6
. 
The motivation behind this approach is based on two major reasons. First, the lower oxidation 
potentials of oligothiophenes
21
 facilitate electropolymerization under mild conditions, i.e. at less 
positive potentials
22
. This will in turn limit the occurrence of side reactions or overoxidation of 
the deposited polymer. Secondly, using oligomers might reduce the α-β‟ defects in the polymer, 
since the oligomer is α-α‟ linked in the starting molecule
23
. The drawback with this method is 
that with an increase in conjugation in the starting monomer, there is a decrease in the reactivity 
of the corresponding cation radical. This inhibits the electropolymerization process, which 
affords low molecular weight polymers, and low conductivities
24
. However, even with these 
limits in mind, the use of oligomers provides the advantage of designing sophisticated structures 
which can be used to synthesize polymers with unique properties.  
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The structure of a monomer can be modified by functionalization of the monomers with electron-
withdrawing groups. For example, it has been shown that introduction of an electron 
withdrawing group at the 3- and/or 4- position of a thiophene significantly decreases the 
polymerization potential and in turn increasing the photovoltaic polymer performance
20a, 23b, 25
. 
Functionalization of monomers with organoborane groups in particular is attractive due to their 
electron deficient nature
20b,22
. However, despite the remarkable properties associated with 
electron-deficient boron, organometallic polymers containing boron, have not been well 
established. This is due in part to the hydrolytic and oxidative sensitivity of many boron-
containing molecules, thereby making the incorporation of boron into polymers synthetically 
difficult. Recent studies however show that not only can boron-containing polymers be obtained 
in high molecular weight, but also the polymers obtained are remarkably stable over long periods 
of time. This can be attributed to the development of new synthetic approaches to the synthesis 
of these polymers, as well as new methods of stabilization of the polymers. Organoborane 
polymers can be classified into three main categories, depending on the chemical structure of the 
organoborane polymer
26
; main-chain functionalized conjugated polymers, side-chain 
functionalized conjugated polymers and side-chain functionalized polyolefins, as shown in 
Figure 3-3. 
 





One of the most recent advancement in the synthesis of polymeric organoboranes is the 
introduction of carboranes into the polymeric system. Carboranes refer to boron clusters which 
can either be neutral or anionic (see Figure 3-4). As a result of their three dimensional aromatic 
character, carboranes in both neutral and anionic forms have unique properties which include, 
low nucleophilicity, high hydrophobic character, as well as high chemical, thermal and optical 
stability
27
. Studies have shown that treatment of the closo carborane with a base readily removes 
a boron to form the nido ion
28
. Complexation of these open carborane cages with metals such as 
Ni, Co and Fe, leads to sandwich-type complexes that are highly stable. The overall charge of 
these complexes will vary from neutral to charged with the overall charge of -1 or -2, depending 
on the oxidation of the metal ion
28c
. These complexes have found practical uses in various fields, 





construction of molecular rotors
31





Figure 3-4: Structures of carborane cages. 
 
We are therefore interested in the preparation of carborane substituted oligothiophenes. These 
compounds incorporate the desirable properties of oligothiophenes as well as those of 
carboranes. We expect the resulting compounds to have remarkable photophysical properties and 
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high stability compared to oligothiophenes without the carboranes groups. We will carry out the 
polymerization (chemical and electrochemical) of the cobaltabis(dicarbollide) oligothiophenes 
and study the physical properties of the resulting polymers. The major challenge in the 
polymerization of the oligothiophenes is the “polythiophene paradox” as mentioned earlier. We 
hope to overcome this problem with the incorporation of the electron deficient carborane into the 
monomeric oligothiophenes.  
3.3 Results and Discussion 
Synthesis of the oligothiophenes was started by Dr. Erhong Hao in our group, and we used 
procedures that he developed to reproduce the compounds and carry out the photophysical 
studies. We began by synthesis of 3 from 2-ethynylthiophene and decaborane in 56% yield as 
shown in Scheme 3-3. Treatment of the carborane with TBAF gave 4 in quantitative yield as a 
NBu4 salt. Compound 5 was then synthesized by reacting 4 with 
t
BuOK and Co(OAc)2 in DME. 
Compound 5 was obtained after air oxidation in 70% overall yield.  
 
Scheme 3-3: Synthesis of thiophene-disubstituted cobaltabis(dicarbollide) 5 
 
The UV-Vis and fluorescence emissions of 3 and 4 were studied in DCM, MeOH and DMF. 
Compound 4 showed an absorption maximum that is higher than 3 in all solvents.  In DCM, for 
example, 4 showed a maximum absorption peak at 271 nm, while 3 showed a maximum 
absorption at 250 nm as shown in Figure 3-5. Next we prepared the bithiophene analogue. We 
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started with 5-bromo-2,2'-bithiophene, which was subjected to Sonogashira coupling using 
trimethylsilyl acetylene, followed by deprotection of the trimethylsilane using K2CO3 to afford 
80% of 7 after flash chromatography as shown in Scheme 3-4. Deprotection using K2CO3 was 
preferred over using 0.1M TBAF, which yielded a product that was difficult to purify, and 
consequently led to low yields. Compound 7 was then reacted with B10H14 to yield 70% of 8. 
This was then followed by degradation using TBAF to give 9 in quantitative yields. Reaction of 
9 with 
t
BuOK and Co(OAc)2 followed by air oxidation afforded 58% of compound 10. 
 




The UV-vis of 8 and 9 were studied in DCM, MeOH and DMF at room temperature. Just like 
compounds 3 and 4, compound 9 showed a maximum absorption peak at a longer wavelength at 
329 nm, compared to the maximum absorption peak at 316 nm for compound 8 in DCM as 












Scheme 3-5: Synthesis of 5-ethynyl-2,2':5',2''-terthiophene, 14. 
 
Our next step was the synthesis of the terthiophene analogue. We started the synthesis by 
brominating 2,2':5',2''-terthiophene using NBS to afford 12 in 76% yield as shown in Scheme 3-
5. This was followed by a Sonogashira coupling reaction with 12 and TMSA. Deprotection of 
the trimethylsilane group was carried out using K2CO3 to afford 67% yield of compound 14. 
Reaction of 14 with B10H14 afforded 15 in 50% yield. Treatment with base afforded 16 in 
quantitative yield. Finally, the reaction of 16 with 
t
BuOK and Co(OAc)2 and Ni(OAc)2 afforded 
17 and 18 in 60 and 43% yield respectively. 
 
Scheme 3-6: Synthesis of terthiophene-disubstituted Co- and Ni-bis(dicarbollide) 17 and 18. 
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The UV-vis of 15 and 16 studied in DCM showed that compound 16 had a maximum absorption 
peak at a longer wavelength than compound 15. Compound 16 has a maximum absorption peak 
at 369 nm, while 15 has a maximum absorption peak at 360 nm in DCM as shown in Figure (3-
7). 
 




An attempt to synthesize the quaterthiophene-disubstituted metallabisdicarbollides proved to be 
futile (see Scheme 3-7). This was as a result of the highly insoluble quaterthiophene compounds 
in regular organic solvents. 
 
Scheme 3-7: Synthesis of ([2,2':5',2'':5'',2'''-quaterthiophen]-5-ylethynyl)trimethylsilane, 20 
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3.4 Electropolymerization of the Cobalt(III)bisdicarbollide Complexes 
Electropolymerization of the cobalt(III)bisdicarbollide complexes was carried out by our 
collaborator, Dr. Bruno Fabre from Université de Rennes 1, France. Both the bis(bithienyl) and 
bis(terthienyl) cobalt(III)bisdicarbollide complexes, 10 and 17, yielded conducting 
metallopolymers. The bis(thiophene) cobalt(III)bisdicarbollide 5 however, did not 
electropolymerize. This can be attributed to the fact that with an increase in the length of the 
oligothiophene substituents, there is a decrease in the oxidative potential. This is supported by 
DFT calculations which indicate that as the length of the oligothiophene substituents increase, 
there is a drastic decrease in the metallic and dicarbollide cage carbon atom contributions, so that 
the HOMOs can be considered almost purely oligothiophene  based (see Figure 3-8). 
 





To help understand the properties of the polymers further, a UV-Vis spectroscopic analysis was 
performed on poly(10) and poly(17). The UV-Vis spectrum was carried out in DCM. For 
compounds 5, 10 and 17, the bands that appeared between 260-280 nm and 460-500 nm can be 
attributed to the cobaltabisdicarbillide center, with the weaker one being due to d-d transition in 
the Co metal. 5, 10 and 17 had λmax values of 250, 325 and 375 nm respectively. The polymers 
poly(10) and poly(17) showed absorption maximum at 410 and 448 nm respectively, which was 
expected since poly(17) assimilates the more conjugated sexithiophene compared to poly(10) 
which assimilates the quaterthiophene components (see Figure 3-9). 























Figure 3-9: Solid-state UV-vis spectra of (A) poly(10) and (B) poly(17) in their doped (solid 




Studies on the surface morphologies of the polymers were carried out by Dr. Zorabel M. LeJeune 
and Dr. Jayne Garno in the Department of Chemistry at LSU. Samples of the doped and undoped 
films of the polymers were characterized using tapping-mode AFM. It was concluded that the 
undoped samples of poly(10) and poly(17) were more compressed and less rugged, compared to 
the doped samples (see Figure 3-10). Furthermore, a study of the polymer conductivity was  
97 
 
      
         I                                                                 II 
Figure 3-10: (A,C,E) Tapping-mode AFM topographs and (B,D,F) corresponding phase 
topographs of neutral undoped (I) and p-doped (II) (A,B) poly(5), (C,D) poly(10) and (E,F) 




carried out using conductive probe AFM. This was done by measuring the current (I) flowing 
through the polymer/gold surface junction against an applied voltage (V). From the profiles, it 
can be seen that the more conjugated poly(17) is more conducting than poly(10) as shown in 
Figure 3-11.  
3.5 Photophysical Studies of Oligothiophenes 
The effect of carboranes on the photophysical properties of the oligothiophenes was studied by 
comparing the absorption and emission of the carborane containing oligothiophenes with those 
of free oligothiophenes. We also compared the quantum yield of the different oligothiophenes as 
well as the solvent effects on quantum yields. 
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Figure 3-11: Current-voltage curves (A) and corresponding semilog plots (B) for as-grown 



















21 - - - - - 
3 250 352 102 0.006 5.0 
4 271 342 71 0.07 3.8 
22 303 362 59 0.018 4.0 
8 317 394, 463 77, 146 0.161 3.8 
9 328 399, 482 71, 154 0.254 4.3 
23 354 407,426 53, 72 0.210 4.1 
15 360 434 74 0.416 4.5 





Figure 3-12: Structures of oligothiophenes studied 
 















21 - - - - - 
3 238 362 124 4.6 x 10
-5
 3.8 
4 268 322 54 4.6 x 10
-3
 3.8 
22 301 370 69 0.031 4.2 
8 316 427 111 0.068 3.8 
9 354 403, 423 49, 69 0.069 4.3 
23 351 403, 424 52, 73 0.063 4.1 
15 371 461 90 0.086 4.3 





















21 - - - - - 
3 267 306 39 0.05 3.3 
4 273 391 118 9.24 x 10
-3
 3.4 
22 305 369 64 0.06 4.0 
8 323 423 100 0.13 3.7 
9 358 408, 430 50, 72 0.10 4.2 
23 356 409, 430 53, 74 0.088 4.5 
15 375 459 84 0.151 4.3 
16 358 410, 429 52, 71 0.105 4.9 
 
From the absorption spectra shown in Table 3-1 and Table 3-2, it was evident that the 
compounds absorbed at longer wavelengths with increase in the number of thiophene rings. In 
addition to this, introduction of a carborane to the system led to a red shift in absorption. This 
can be attributed to the fact that carborane cages are aromatic 3-D structures, therefore, there is 
an increase in conjugation of the system. We also studied the quantum yields of the 
oligothiophenes in different solvents. As a common practice, the determination of quantum 
yields of an unknown is performed by comparing with a standard of known fluorescence
33
. In 
our case, the quantum yields were measured at 298K, using 3-chloro-7-methoxy-4-
methylcoumarin  ФF = 0.12 in cyclohexane) as a standard
34
. The general trend for the quantum 
yields in DCM and MeOH was that there was an increase in quantum yield with an increase in 
number of thiophene rings, and also both the closo- and nido- carboranes enhanced the quantum 
yields. Interestingly, the trend was not observed with DMF as the solvent. In this case, the closo-
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carborane was observed to enhance the quantum yield, while the nido-carborane dimished it. 
Studies have shown that in some solvents, the nido-carborane does indeed diminish the quantum 
yield
33
. A number of factors can be responsible for this observation. The first reason is the 
presence of photoinduced electron transfer in polar solvents which lead to low fluorescence 
yields
33, 35
. Secondly, presence of hydrogen bonding in polar solvents reduces quantum yields by 
enhancing the non-radiative decay
33, 36
. 
3.6 Biological Studies 
In collaboration with Dr. Xiaoke Hu, we performed in vitro studies on these compounds to 
determine whether they were viable candidates for PDT and/or BNCT. The reasoning behind this 
was based on the fact that thiophenes are known to have many desirable properties, including 
their stability, and of course their photophysical properties, which have led to their being used in 
many optical devices
11
. Furthermore, the presence of the boron cage substituent makes these 
compounds promising candidates for boron delivery in BNCT applications. In addition to this, 
the small size of the molecules will hopefully make it easy for them to cross the BBB in the 
treatment of brain tumors.  
The phototoxicity study on both the closo- and nido- containing oligothiophenes. This study was 
important because the uptake of electronic energy of a photon by a UV-absorbing molecule 
initiates photochemically damaging processes in the cells
37
. When a molecule absorbs a photon, 
it moves from the stable singlet ground state to either a singlet excited state or a triplet excited 
state. The triplet excited states have longer lifetimes than singlet excited states and hence, can 
take part in various chemical reactions. An alternative route for this triplet excited state is the 
transfer of triplet energy to oxygen to form singlet oxygen, 
1
O2, which in the case of PDT 
destroys tumor cells. It is therefore important for the photosensitizer to not only be phototoxic, 
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but low concentrations of the compounds are required to bring about the necessary cancerous cell 
destruction. In our case, the phototoxicity assays for all the oligothiophenes were carried out in 
vitro using human carcinoma HEp2 cells. After incubating the cells for 20-24 h, the cells were 
exposed to low light dose (1 J cm
-1
), and none of the oligothiophenes were found to be cytotoxic 
(see Figure 3-13). It is important for a compound that is a potential PDT photosensitizer to have 
low dark toxicity, but be cytotoxic in presence of light. For the dark toxicity test, the assays for 
all the oligothiophenes were carried out in vitro using human carcinoma HEp2 cells. They were 
then incubated for 20-24 h. At concentrations of 10μ , all compounds were found to be non-
toxic to the cells in the dark as shown in Figure 3-14. These results indicated that despite the 
compounds not being potential candidates for PDT, they could potentially be used in BNCT. 
From cellular uptake experiments conducted over 24 h, compound 15 was found to accumulate 
faster and at a higher extent than all other compounds that were tested as shown in Figure 3-15. 
 
Figure 3-13: Phototoxicities of Oligothiophenes 3 (red), 4 (green), 8 (blue), 9 (purple), 15 
(maroon) and 16 (yellow) toward HEp2 cells using 1 J cm
-1





Figure 3-14: Dark Toxicity of Oligothiophenes 3 (red), 4 (green), 8 (blue), 9 (purple), 15 
(maroon) and 16 (yellow) toward HEp2 cells using Titer Blue assay. 
 
 
Figure 3-15: Time-dependent uptake for oligothiophenes 4 (green), 8 (blue), 9 (purple), 15 
(maroon) and 16  yellow) at 10μ  by HEp2 cells. 
 
It is important to study the intracellular localization of compounds to evaluate their potential for 
tumor destruction. In our study, the subcellular localization of compounds 3, 4, 8, 9, 14, and 15 
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in HEp2 cells was studied. At concentrations of 10 μ , the compounds were allowed to incubate 
overnight and thereafter evaluated by fluorescent microscopy (see Figures 3-16, 3-17 and 3-18). 
Table 3-4: Summary of subcellular localization sites of oligothiophenes  
Compound Media/solvent Sub-cellular localization 
3 DMSO/Cremophor Mitochondria, Golgi, Lysosome 
4 DMSO/Cremophor Mitochondria, Golgi, Lysosome 
8 DMSO/Cremophor ER (small part), Lysosome (small part), Mitochondria, 
Golgi 
9 DMSO/Cremophor Mitochondria, Lysosome, Golgi 
15 DMSO/Cremophor ER (small part), Golgi, Lysosome, Mitochondria 




     3       4 
Figure 3-16: Subcellular localization of 3 and 4 in HEp2 cells at 10μ  for 24 h.  a) Phase 
contrast, (b) overlay of 3 and 4 and phase contrast, (c) ER-tracker green fluorescence (e) 
MitoTracker Green Fluorescence (g) LysoSensor Green fluorescence, (i) BODIPY Ceramide 
fluorescence, (d), (f), (j) overlays of organelle tracers with 3 and 4. Scale bar: 10 μ . 
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8     9 
Figure 3-17: Subcellular localization of 8 and 9 in HEp2 cells at 10μ  for 24 h.  a) Phase 
contrast, (b) overlay of 8 and 9 and phase contrast, (c) ER-tracker green fluorescence (e) 
MitoTracker Green Fluorescence (g) LysoSensor Green fluorescence, (i) BODIPY Ceramide 
fluorescence, (d), (f), (j) overlays of organelle tracers with 8 and 9. Scale bar: 10 μ . 
   
    15     16 
Figure 3-18: Subcellular localization of 15 and 16 in HEp2 cells at 10μ  for 24 h.  a) Phase 
contrast, (b) overlay of 15 and 16 and phase contrast, (c) ER-tracker green fluorescence (e) 
MitoTracker Green Fluorescence (g) LysoSensor Green fluorescence, (i) BODIPY Ceramide 
fluorescence, (d), (f), (j) overlays of organelle tracers with 15 and 16. Scale bar: 10 μ . 
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As previously discussed, all oligothiophenes were foud to emit at wavelengths between 322 and 
459, as shown in Tables 3-1, 3-2 and 3-3. However, when carrying out the sub-cellular 
localization studies, it was observed that all the studied oligothiophenes emitted at wavelengths > 
500 nm. A possible explanation for this observation could be that in cell media, these 
oligothiophenes undergo some form of polymerization so that they form more conjugated 
systems, which emit at longer wavelengths than the corresponding oligothiophenes. Further 
studies are currently going on to establish the reason behind this behavior. 
3.7 Conclusions 
Synthesis of various caboranyl-substituted oligothiophenes was successfully carried out. The 
compoundss were purified using silica gel chromatography and obtained in good yields. 
Complexation of the open cage carborane derivatives with Co and Ni afforded the highly stable 
Co- and Ni- bis(dicarbollide) compounds respectively. A study on the photophysical properties 
of the oligothiophenes revealed that the wavelength of absorption increases with an increase in 
the number of thiophene rings. In addition it was observed that the nido-carborane containing 
oligothiophene absorbed at longer wavelength and recorded higher quantum yields than the 
closo-carborane containing oligothiophenes. However, the effects of solvent polarity on the 
quantum yields was observed when DMF was used. It was observed that in DMF, the nido-
carborane containing oligothiophenes recorded lower quantum yields than their corresponding 
closo-caborane containing oligothiophenes. From the biological data obtained, we noted that the 
synthesized oligothiophenes were potential candidates for use in BNCT. Further work is being 
carried out by our group to help us understand why the oligothiophenes emit at longer 






All reactions were monitored by thin layer chromatography (TLC) using 0.25mm silica gel plates 
purchased from Sorbent technologies, with or without UV indicator (60F-254). All column 





NMR spectra were obtained either on a DPX-250 or AV-400 Bruker spectrometer. Chemical 









C). MALDI-TOF mass spectra were obtained on a Bruker OmniFLEX 
MALDI-TOF mass spectrometer. ESI-TOF was obtained on Agilent 6210. Reagents and 
solvents were obtained from either Sigma-Aldrich or Fischer Scientific, and were used without 
further purification. Decaborane was obtained from Katchem, Inc. (Czech Republic) and all 
other reagents were obtained from Sigma-Aldrich and used without further purification. 
 
UV-Visible Spectroelectrochemistry 
UV-visible absorption spectra were recorded on a Shimadzu Multispec-1501 spectrophotometer 
(190-1100 nm scan range)  using quartz SUPRASIL cells (1 cm). The polymer films were grown 
on an indium tin oxide (ITO)-coated glass slide electrode. 
 
Computational Analysis 
Density functional theory (DFT) calculations and performed with the hybrid Becke three-
parameter exchange functional and the Lee-Yang-Parr nonlocal correlation functional (B3LYP) 
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implemented in the Gaussian 03 (Revision D.02), program suite using the LanL2DZ basis set. 




Conducting Probe Atomic Force Microscopy (AFM) 
Samples of doped and undoped cobaltabisdicarbollide-functionalized polythiophene films were 
prepared on gold surfaces on glass using controlled potential electropolymerization. The 
substrates have a gold coating (1000 Å) on a 50 Å layer of Cr formed on glass. Surface 
characterizations were accomplished in ambient conditions using a model 5500 scanning probe 
microscope (SPM). Characterizations of the surface morphology were carried out using tapping 
mode atomic force microscopy (AFM). Monolithic silicon probes (PPP-NCL) were used for 
tapping mode experiments. A multipurpose SPM scanner with was used for imaging, with 
interchangeable nose cones for either tapping mode or conductive probe AFM experiments. For 
current imaging and I-V measurements, a preamp is integrated within the nose cone. Conductive 
probe AFM experiments were carried out using a V-shaped conductive AFM tip (CSC11/Ti-Pt, 
coated with 10 nm Pt layer on a sublayer of 20 nm Ti.  
 
Cell Culture 
All tissue culture media and reagents were obtained from Invitrogen. HEp2 cells were plated on 
LabTek II two chamber coverslips. They were allowed to grow for a duration of 24-48h. 
Compounds being investigated were then added at 10μ  and incubated overnight. This was then 
followed by the addition of the tracers, which were added concurrently with the compound for 
the remainder of the incubation period. The tracers used were: BODIPY Ceramide, ERTracker 
Green, LysoSensor Green and MitoTracker Green. Distribution of the compound was determined 
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using a Zeiss AxioVert 200M inverted fluorescent microscope fitted with standard texas Red, 
FITC, DAPI and Cy5LP filter sets. 
Phototoxicity 
The HEp2 cells were placed at 7500 per well in costar 96-well plate and allowed to grow 
overnight. Compounds were diluted to 100μ  in medium, and then diluted to the final working 
concentrations of 6.25μ .  If D SO was required to dissolve the compound, a 1% DMSO 
concentration was maintained throughout the experiment and dilutions by replacing the growth 
medium with medium plus 1% DMSO before making dilutions) The cells were then incubated 
overnight (20-24h). The loading medium was then removed and the cells were fed medium 
containing 50m  HEPES pH 7.4. The plate was placed on ice. It was then exposed to a 610nm 
LP filtered light from a halogen lamp for 20 minutes   1 Jcm
-2
). IR radiation was filtered using a 
10nm water layer contained in a petri dish placed on top of the 96 well plate. The medium was 
removed and cells fed medium containing 20μL CellTiter Blue per 100μL medium and then 
incubated for 4 hours. This was followed by conversion of the substrate by viable cells which 
was measured by fluorescence.. 
Dark Toxicity 
HEp2 cells were plated at 7500 cells per well in Costar 96-well plates and allowed to grow for 
48h. Compounds were diluted to 100μ  in medium, and then diluted to 6.5μ .  If D SO was 
required to dissolve the compound, a 1% DMSO concentration was maintained throughout the 
experiment and dilutions by replacing the growth medium with medium plus 1% DMSO before 
making dilutions) The cells were incubated overnight (20-24h). Loading medium was then 
removed and cells were fed medium containing 20μL CellTiter Blue per 100μL medium and 
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then incubated for 4h. This was followed by conversion of the substrate by viable cells which 
was measured by fluorescence at 570/615nm. 
Time Dependent Cellular Uptake 
HEp2 cells were plated at 7500 per well on Costar 96-well dish and allowed to grow for 48h. 
Compounds were diluted to a 20μ  stock in medium. Equal volume of the stock was added in 
triplicate wells containing cells  100μL) to give a final concentration of 10μ . The cells were 
exposed to the compounds for 1h, 2h, 4h, 8h and 24h. At the end of the incubation time, the 
medium was removed and the cells washed with 200μL of PBS. After removal of PBS, the cells 
and compounds were then solubilized using 100μL of 0.25% Triton X-100 in PNS. To determine 
the compound concentration, fluorescence emission was read using FLUOstar plate reader using 
excitation/emission wavelengths appropriate for the compound under study. The cell numbers 
were quantified using the CyQuant cell proliferation assay reagent. 
Synthesis of Thiophene-2-o-carborane (3) 
Decarborane (2.6g, 21.26 mmol) was dissolved in 30 mL dry toluene. To this solution was added 
diethylsulfide (4.22g, 46.78 mmol) and the reaction mixture allowed to stir at 40oC for 3 h, and 
then at 60oC for 2h. 2-ethynylthiophene (2.3g, 21.26 mmol) was dissolved in 30 mL dry toluene 
and this solution added to the decarborane solution. The final reaction mixture was allowed to 
reflux for 48h. After the 48h, it was allowed to cool to room temperature, after which the solvent 
was evaporated under vacuum. The resulting residue was purified by column chromatography 
using 2:8 DCM/Hexane as eluent. The product was obtained as white crystals in 56% yield. 
1
H 
NMR (CDCl3, 250 MHz) δ 7.25-7.27 (1H, m), 7.20-7.21 (1H, m), 6.90-6.92 (1H, m), 3.86 (1H, 
s), 1.50-3.50 (br, 10H). 
13





NMR (CDCl3, 128 MHz, BF3.OEt2)δ -3.3 (d, 
1
J(B,H) ) 146 Hz, 1B) -6.6 (d, 
1
J(B,H) ) 147 Hz, 
1B), -10.0 to -16.0 (br m, 8B). MALDI-TOF [M + H]+ 226.3. HRMS(ESI) m/z calcd for 
C6H13B10S, 226.1739; found, 226.1746. 
 
Synthesis of Tetrabutylammonium Thiophene-2-o-nido-carborane (4) 
Thiophene-2-o-carborane (0.23g, 1.02 mmol) was dissolved in 10 mL dry THF. To this solution, 
2.04 mL of TBAF (1.0M in THF) was added under a nitrogen atmosphere. The reaction mixture 
was stirred at 60
o
C for 2h and the reaction monitored by TLC to make sure no more starting 
material was present. It was then poured into 50mL water and extracted with EtOAc. The 
organic layers were dried over anhydrous Na2SO4. It was then filtered, and the solvent removed 
under vacuum. The final residue was purified by passing through a pad of silica gel using EtOAc 
as eluent. The product was obtained as a white solid in 96% yield. 
1
H NMR (acetone-d6, 250 
MHz) δ 6.95 (1H, m), 6.74 (1H, m), 6.65 (1H, m), 3.37 (8H, m), 3.35 (1H, br),1.75 (8H, m), 
1.50-3.50 (br, 9H, BH), 1.37 (8H, m, CH2), 0.91 (12H, m, CH3), -2.03-2.50 (1H, br,BH). 
13
C 
NMR (CDCl3, 100 MHz) 150.9, 126.3, 121.9, 121.5,60.3, 59.0, 24.0, 21.0, 19.7, 13.6. 
11
B NMR 
(CDCl3, 128 MHz,BF3.OEt2) δ -10.0 to -16.0 (br m, 3B), -18.0 to -20.0 (br m,3B), -24.6 (d, 
1
J 
(B,H) ) 149 Hz, 1B), -34.7(dd, 
1
J (B,H) ) 43.8Hz, 
1
J (B,H) ) 43.7 Hz, 1B), -37.6 (d, 
1
J(B,H) ) 138 
Hz, 1B).HRMS (ESI) [M-NBu4]-m/z calcd for C6H14B9S, 214.1657; found,214.1664. 
 
Synthesis of Tetrabutylammonium Cobalt(III) Bis-(thiophene-2-o-nido-carborane) (5) 
Tetrabutylammonium thiophene-2-o-nido-carborane (0.46g, 1.00mmol), anhydrous CoCl2 
(1.35g, 10.00 mmol) and  tBuOK (1.12 g, 10.0 mmol), were dissolved in 10 mL of anhydrous 
dimethoxyethane. The reaction was placed under nitrogen atmosphere and allowed to reflux for 
30 h. It was then cooled to room temperature and the precipitate that formed filtered off. The 
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filtrate was diluted using 50 mL dichloromethane and washed with  n-Bu4NHSO4 aqueous 
solution. The organic layers were dried over anhydrous Na2SO4 and dried under a vacuum. The 
final residue was purified by column chromatography using DCM as the eluent. The product was 
obtained as a yellow powder 0.25g ,70 % yield. 
1
H NMR (acetone-d6, 250 MHz) δ 7.23 (1H,m), 
7.14 (1H, m), 6.89 (2H, m),6.76 (1H, m), 6.64 (1H, m), 4.26 (1H, s), 3.42 (8H, m), 3.23 (1H, s), 
1.77 (8H,m), 1.53-3.40 (18H, br), 1.38 (8H, m), 0.95-1.01 (12H, m). 
13
C NMR (CDCl3, 100 
MHz) 125.7,125.8, 123.2, 59.1, 30.9, 24.1, 19.7, 13.7. 
11
B NMR (CDCl3, 128 MHz, BF3.OEt2) δ 
9.0-30.0 (br m, max at 5.9, -0.5, -8.8 and -30.8, 18B) ppm. HRMS (ESI) [M-NBu4]
-
 m/z calcd for 
C12H26B18S2Co, 488.26; found, 488.2628. 
 
Synthesis of ([2,2'-bithiophen]-5-ylethynyl)trimethylsilane (6) 
To a mixture of 5-bromo-2,2'-bithiophene (1.0g, 4.1mmol), PdCl2(PPh3)2 (0.143g, 0.204mmol), 
CuI (0.039g, 0.204mmol) in DIPA (60ml) was added TMSA (1.41ml, 10.2mmol) dropwise 
under argon atmosphere. The mixture was stirred at room temperature for 6h. The reaction was 
quenched by pouring into water and extracting with ethyl acetate. The organic layers were 
concentrated under reduced pressure and the residue purified by column chromatography using 
20%DCM in hexanes to produce 76% product as a yellow solid. 
1
H NMR (CDCl3, 400MHz) δ 





= 4Hz, ArH), 0.26 (9H, s, CH3). 
Synthesis of 5-ethynyl-2,2'-bithiophene (7) 
Protecting group was removed from ([2,2'-bithiophen]-5-ylethynyl)trimethylsilane, 6, (0.71g, 
2.71mmol) by reacting it with K2CO3 (1.12g, 8.13mmol) at room temperature for 2h. The 
reaction was quenched by addition of water. This was diluted with Et2O and washed with water. 
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The organic layer was dried over Na2SO4 and evaporated under pressure. The residue was 
purified using column chromatography using 20%DCM in hexanes to produce 80% product as a 
yellow solid. 
1
H NMR (CDCl3, 400 Hz) δ 7.25  1H, d, J= 1Hz, ArH), 7.19 (2H, m, ArH), 7.03 
(2H, d, J= 4Hz, ArH), 3.41 (1H, s, CH). 
Synthesis of 2,2′-Bithiophene-5-o-carborane (8) 
Decarborane (0.072g, 0.57mmol), 2-ethynylbithiophene (0.062g, 0.33mmol), and dry CH3CN 
(0.5ml) were dissolved in  dry toluene (1.5ml). The reaction mixture was stirred at 80
o
C under 
nitrogen atmosphere for 24h. It was then cooled to room temperature, and methanol (1.0ml) 
added to the reaction mixture. It was then stirred for 30 min followed by drying under vacuum. 
The final residue was purified by column chromatography using 10% DCM in hexanes as eluent. 
The title compound was obtained as a light brown solid, in 70% yield. 
1
H NMR (CDCl3, 250 
MHz) δ 7.27 (1H, d, J ) 5.10 Hz, ArH), 7.18 (1H, d, J ) 3.00 Hz, ArH), 7.09 (1H, d, J ) 3.73 Hz, 
ArH), 7.03 (1H, t, J ) 4.48 Hz, ArH), 6.94 (1H, d, J ) 3.71 Hz, ArH), 3.86 (1H, s, CH), 1.50-3.50 
(br, 10H, BH).
13
C NMR (CDCl3, 63 MHz) 140.4, 136.0, 135.2, 131.1, 128.5, 126.2, 125.3,  
123.8, 72.4, 63.8. 
11
B NMR (CDCl3, 128 MHz, BF3.OEt2)δ -3.4 (d, 
1
J(B,H) ) 145 Hz, 1B), -6.5 
(d, 
1
J(B,H) ) 141 Hz, 1B), -10.0 to -16.0 (br m, 8B). MALDI-TOF [M +H]+ 309.5. HRMS (ESI) 
m/z calcd for C10H15B10S2, 307.1630;found, 307.1623. 
 
 
Synthesis of Tetrabutylammonium 2,2′-Bithiophene-5-o-nido-carborane (9) 
2,2′-Bithiophene-5-o-carborane (0.50g, 1.62 mmol) was dissolved in 20 mL dry THF. To this 
solution, 3.24 mL of TBAF (1.0M in THF) was added under a nitrogen atmosphere. The reaction 
mixture was stirred at 60
o
C for 2h and the reaction monitored by TLC to make sure no more 
starting material was present. It was then poured into 100 mL water and extracted with EtOAc. 
114 
 
The organic layers were dried over anhydrous Na2SO4. It was then filtered, and the solvent 
removed under vacuum. The final residue was purified by passing through a pad of silica gel 
using EtOAc as eluent. The product was obtained as a yellow solid, in 94% yield. 
1
H NMR 
(acetone-d6, 250 MHz) δ 7.27(1H, dd, J ) 1.11 Hz, J ) 4.02 Hz, ArH), 7.08 (1H, dd, J ) 1.07Hz, J 
) 2.50 Hz, ArH), 6.98 (1H, dd, J )5.04 Hz, J )1.43 Hz,ArH), 6.88 (1H, d, J ) 3.69 Hz, ArH), 6.58 
(1H, d, J ) 3.73 Hz,ArH), 3.36-3.43 (8H, m, CH2), 2.87 (1H, br s, CH), 1.73-1.83(8H, m, CH2), 
1.50-3.50 (br, 9H, BH), 1.35-1.46 (8H, m, CH2),0.91-1.00 (12H, m, CH3), -2.51 (br, 1H, BH).
13
C 
NMR (acetone-d6,63 MHz) 152.1, 138.8, 133.5, 128.6, 124.3, 123.7, 123.2,122.9, 80.5, 77.1, 
59.2, 24.3, 20.3, 13.8. 
11
B NMR (CDCl3, 128MHz, BF3.OEt2) δ -10.0 to -16.0 (br m, 3B), -18.0 
to -20.0(br m, 3B), -24.6 (d, 
1
J (B,H) ) 149 Hz, 1B), -34.7 (dd, 
1
J (B,H)) 43.8 Hz, 
1
J (B,H) ) 43.7 
Hz, 1B), -37.6 (d, 
1
J(B,H) ) 138 Hz,1B). HRMS (ESI) [M-NBu4]- m/z calcd for C10H16B9S2, 
298.1582;found, 298.1586. 
 
Synthesis of Tetrabutylammonium Cobalt(III) Bis(2,2′-bithiophene-5-o-nido-carborane) 
(10) 
 
Tetrabutylammonium 2,2′-Bithiophene-5-o-nido-carborane (0.022g, 0.07mmol), anhydrous 
CoCl2 (0.095g, 0.73 mmol) and  tBuOK (0.082 g, 0.73 mmol), were dissolved in 0.5 mL of 
anhydrous dimethoxyethane. The reaction was placed under nitrogen atmosphere and allowed to 
reflux for 30 h. It was then cooled to room temperature and the precipitate that formed filtered 
off. The filtrate was diluted using 10 mL dichloromethane and washed with  n-Bu4NHSO4 
aqueous solution. The organic layers were dried over anhydrous Na2SO4 and dried under a 
vacuum. The final residue was purified by column chromatography using DCM as the eluent. 
Product was obtained as a dark yellow solid in 58% yield. 
1
H NMR (acetone-d6, 250 MHz) δ 
7.19 (3H, m), 7.06 (2H, m), 6.98 (2H, m), 6.79 (2H, br s), 6.41 (1H, br s), 4.17 (1H, br s),3.32 
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(1H, br s), 3.07 (8H, m), 1.60 (8H,m), 1.50-3.50 (18H, br, BH), 1.37 (8H, m),1.01 (12H, m). 
13
C 
NMR (CDCl3, 100 MHz) 127.8, 127.5, 124.5, 123.7, 123.0, 122.9, 59.0, 43.4, 24.2, 19.6, 
13.5.
11
B NMR (CDCl3, 128 MHz, BF3.OEt2) δ 9.0-30.0 (br m, max at 5.9, -0.5, -8.8 and -30.8, 
18B) ppm. HRMS (ESI) [M-NBu4]
-
m/z calcd for C20H30B18S4Co, 652.2346; found, 652.2362. 
 
Synthesis of Tetrabutylammonium Nickel(III) Bis(2,2′-bithiophene-5-o-nido-carborane) 
(11) 
 
Procedure similar to synthesis of 10. 
1
H NMR (acetone-d6, 400 Hz) δ 7.28  3H, m), 7.07  2H, 
m), 7.02 (2H, m), 6.67 (2H, br s), 6.39 (1H, br s), 4.15 (1H, br s), 3.28 (1H, br s), 3.10 (8H, m), 
1.59 (8H, m), 1.60-3.33 (18H, br), 1.29 (8H, m), 1.04 (12H, m). 
Synthesis of 5-bromo-2,2':5',2''-terthiophene (12) 
2,2':5',2''-Terthiophene (2.0g, 8.0mmol) was dissolved in CCL4 (80ml) and NBS (1.41g, 
8.0mmol) was added to the solution. The solution was stirred for 48 h at room temperature. The 
solution was then filtered through cotton wool to remove the imide. The filtrate was dried under 
pressure, and resulting residue purified by column chromatography using 20% DCM in hexanes 
to afford product in 76% yield as a yellow solid. 1H  N R  CDCl3, 400 Hz) δ 7.28  2H, m, 




= 5Hz, ArH), 6.93 
(IH, d, J= 4Hz, ArH). 
Synthesis of ([2,2':5',2''-terthiophen]-5-ylethynyl)trimethylsilane (13) 
To a mixture of 5-bromo-2,2':5',2''-terthiophene (2.0g, 6.11mmol), PdCl2(PPh3)2 (0.21g, 
0.31mmol), CuI (0.06, 0.31mmol) in DIPA (120ml) was added TMSA (2.12ml, 15.28mmol) 
dropwise under argon atmosphere. The mixture was stirred at room temperature for 6 h. The 
reaction was quenched by pouring into water and extracted with EtOAc and dried under reduced 
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pressure. Product was purified by column chromatography using 20% DCM in hexanes to afford 
67% of product as a yellow solid. 1H N R  CDCl3, 400 Hz) δ 7.26  2H, m), 7.15  2H, m), 




= 5Hz), 6.93 (1H, d, J= 4Hz), 0.23 (9H, s) 
Synthesis of 5-ethynyl-2,2':5',2''-terthiophene (14) 
Protecting group was removed from ([2,2':5',2''-terthiophen]-5-ylethynyl)trimethylsilane (0.5g, 
1.45mmol) by reacting it with K2CO3 (0.6g, 4.35mmol) at room temperature for 2h. The reaction 
was quenched by addition of water. This was diluted with Et2O and washed with water. The 
organic layer was dried over Na2SO4 and evaporated under pressure. The residue was purified 
using column chromatography using 20%DCM in hexanes to produce 67% product as a yellow 
solid. 
1
H NMR (CDCl3, 400 Hz) δ 7.23  1H, m), 7.18  1H, m), 7.07  1H, m), 7.02  2H, m), 
6.98 (1H, d, J = 4Hz), 6.92 (1H, d, J = 4Hz), 3.42 (1H, s) 
Synthesis of 2,2′,5′,2′′-Terthiophene-5-o-carborane (15) 
Decarborane (0.12g, 0.97mmol), 5-ethynyl-2,2':5',2''-terthiophene (0.148g, 0.54mmol), and dry 
CH3CN (1.48 ml) were dissolved in  dry toluene (6.4 ml). The reaction mixture was stirred at 
80
o
C under nitrogen atmosphere for 24h. It was then cooled to room temperature, and methanol 
(1.0ml) added to the reaction mixture. It was then stirred for 30 min followed by drying under 
vacuum. The final residue was purified by column chromatography using 10% DCM in hexanes 
as eluent. Product was obtained as a yellow solid in 50% yield. 
1
H NMR (CD2Cl2, 300 MHz) δ 
7.29 (1H, br s), 7.22 (1H, br s), 7.07 (4H, m), 6.97 (1H, br s), 3.90 (1H, s), 1.47-3.50 (br, 10H, 
BH).
13
C NMR (CD2Cl2, 63 MHz) 140.0, 138.8, 136.7, 135.0, 134.7, 131.0, 128.2, 125.7, 125.2, 
125.0, 124.8, 123.6, 72.7, 64.2. 
11
B NMR (CDCl3, 128 MHz, BF3.OEt2) δ -3.2 (d, 
1
J(B,H) ) 143 
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Hz, 1B), -6.4 (d, 
1
J(B,H) ) 148 Hz, 1B), -10.0 to -16.0 (br m, 8B). MALDI-TOF [M + H]+ 391.3. 
HRMS(ESI) m/z calcd for C14H17B10S3, 390.1468; found, 390.1475. 
 
Synthesis of Tetrabutylammonium 2,2′,5′,2′′-Terthiophene-5-o-nido-carborane (16) 
2,2′:5′,2′′-Terthiophene-5-o-carborane (0.042g, 0.108 mmol) was dissolved in 1.8 mL dry THF. 
To this solution, 0.22 mL of TBAF (1.0M in THF) was added under a nitrogen atmosphere. The 
reaction mixture was stirred at 60
o
C for 2h and the reaction monitored by TLC to make sure no 
more starting material was present. It was then poured into 1.8 mL water and extracted with 
EtOAc. The organic layers were dried over anhydrous Na2SO4. It was then filtered, and the 
solvent removed under vacuum. The final residue was purified by passing through a pad of silica 
gel using EtOAc as eluent. The product was obtained as a yellow solid in 80% yield. 
1
H NMR 
(acetone-d6, 250 MHz) δ 7.43 (1H,d, J= 4.91 Hz), 7.25 (1H, d, J = 3.41 Hz), 7.16 (1H,d, J = 3.71 
Hz), 7.05-7.08 (2H, m), 6.95 (1H, d, J =3.61 Hz), 6.59 (1H, d, J = 3.64 Hz), 3.40-3.47 (8H,m,), 
3.02 (1H, br s), 1.76 (8H, m), 1.52-3.50(br, 9H), 1.39 (8H, m), 0.96 (12H, m),-2.40 (br, 1H, 
BH).
13
C NMR (acetone-d6, 63 MHz) 152.1, 137.2,137.1, 135.2, 132.6, 128.6, 125.3, 124.9, 
124.1, 123.7, 123.6,122.8, 80.8, 67.7, 59.0, 24.2, 20.0, 13.6. 
11
B NMR (CDCl3,128MHz, 
BF3.OEt2) δ -10.0 to -16.0 (br m, 3B), -18.0 to -20.0(br m, 3B), -24.6 (d, 
1
J (B,H) ) 149 Hz, 1B), 
-34.7 (dd, 
1
J (B,H)) 43.8 Hz, 
1
J (B,H) ) 43.7 Hz, 1B), -37.6 (d, 
1
J(B,H) ) 138 Hz,1B). HRMS 
(ESI) [M-NBu4]
-
 m/z calcd for C14H18B9S3, 380.1462; found, 380.1466. 
Synthesis of Tetrabutylammonium Cobalt(III) Bis-(2,2′,5′,2′′-terthiophene-5-o-nido-
carborane) (17) 
 
Tetrabutylammonium 2,2′,5′,2′′-Terthiophene-5-o-nido-carborane (0.005g, 0.013mmol), 
anhydrous CoCl2 (0.0095g, 0.073 mmol) and  tBuOK (0.0082 g, 0.073 mmol), were dissolved in 
0.1 mL of anhydrous dimethoxyethane. The reaction was placed under nitrogen atmosphere and 
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allowed to reflux for 30 h. It was then cooled to room temperature and the precipitate that formed 
filtered off. The filtrate was diluted using 10 mL dichloromethane and washed with  n-
Bu4NHSO4 aqueous solution. The organic layers were dried over anhydrous Na2SO4 and dried 
under a vacuum. The final residue was purified by column chromatography using DCM as the 
eluent. Product was obtained as a dark yellow solid in 60% yield. 
1
H NMR (acetone-d6, 
250MHz) δ 7.41 (2H, m), 7.26 (2H, m), 7.18 (2H, m), 7.05 (4H, m), 6.86 (2H, m), 6.55 (2H, m), 
3.62 (1H, br s), 3.44 (8H, m), 3.10 (1H, br s), 1.76 (8H, m), 1.52-3.48 (18H, br), 1.39 (8H, m), 
0.97 (12H, m). 
13
C-NMR (CDCl3, 100 MHz) 138.1, 137.9, 135.1, 132.5, 127.5, 126.2, 124.8, 
123.9, 123.5,122.7, 68.7, 58.9, 42.6, 24.2, 20.0, 13.6. 
11
B NMR (CDCl3, 128 MHz,BF3.OEt2) δ 
9.0-30.0 (br m, max at 5.9, -0.5, -8.8 and -30.8,18B) ppm. HRMS (ESI) [M-NBu4]
-
 m/z calcd for 
C28H34B18S6Co, 816.2129; found, 816.2115. 
 
Synthesis of Tetrabutylammonium Nickel(III) Bis-(2,2′,5′,2′′-terthiophene-5-o-nido-
carborane) (18) 
 
Procedure similar to synthesis of compound 17. 47% yield.  
1
H NMR (CDCl3, 400 Hz) δ 7.39 
(2H, m), 7.23 (2H, m), 7.17 (2H, m), 7.07 (4H, m), 6.92 (2H, m), 6.55 (2H, m), 3.57 (1H, br s), 
3.34-3.41 (8H, m), 3.07 (1H, br s), 1.69-1.78 (8H, m), 1.47-3.46 (18H, br), 1.33-1.41 (8H, m), 
0.92-0.98 (12H, m). MALDI-TOF calcd for  for C28H34B18S6Ni, 816.21; found 816.706. 
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CHAPTER 4: SYNTHESIS OF TETRABENZOPORPHYRINS 
CONJUGATED WITH POLYAMINES FOR PDT 
4.1 Introduction 
Porphyrins and pthalocyanines (see Figure 4-1) represent two of the most studied classes of 
conjugated systems
1
. Because of their unique optical chemical, and photophysical properties, 









. PDT and BNCT are two relatively new bimodal therapies, which require the 
use of sensitizers for the treatment of cancer.  
 
Figure 4-1: Structures of porphyrin and phthalocyanine 
 
Studies have shown that not only can porphyrins act as photosensitizers, but they also have been 
found to have a high affinity for tumor cells
5
. The drawback for the use of porphyrins is that at 
the wavelengths at which they absorb, bodily tissues also strongly absorb light, and this limits 
their clinical use
1
. Because of this, there have been many attempts to modify the core of the 
porphyrin chromophore so as to shift their absorption to the red and near IR regions. This has led 
to synthesis and investigation of new classes of porphyrins which include porphyrins isomers, 
expanded porphyrins, hydroporphyrins, and π-extended porphyrins. Π-extended porphyrins make 
up a class of porphyrinoid chromophores, most of which contain fused aromatic rings via the β-
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carbon atoms, as well as π-extended porphyrins at the meso-position. Examples of the π-
extended porphyrins can be seen in Figure 4-2.  
 
 




Among the π-extended porphyrins, tetrabenzoporphyrin (TBP) has received a lot of interest. As 
its name indicates, TBP contains four β,β‟-fused benzene rings onto a porphyrin macrocycle. 
Incorporation of these benzene rings leads to extension of the π-conjugation, which in turn leads 
to a bathochromic shift in the absorption
1
. These optical properties make TBP promising 
candidates for PDT, as well as in electronic devices and sensors. The first ZnTBP, 5, was 
synthesized by Helberger and co-workers (see Scheme 4-1). They reacted o-cyanoacetophenone 
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with different phthalimidines to accomplish this
6
. Because of its physicochemical properties, 
TBP drew a lot of attention in the research world, as different groups came up with different 
procedures for synthesizing them. Linstead and co-workers prepared ZnTBP 5 from o-
cyanocinnamic acid and also from 3-carboxymethylphthalimidine
7
. Vogler and Kunkely later 
came up with a different procedure  for the same TBP which required reaction of 2-acetylbenzoic 









. One thing all these 
procedures have in common is the fact that they all require harsh conditions, of heating at 300
o
C 
often in the presence of an acid. This made the synthesis of functionalized TBPs challenging and 
also led to low yields.  
 
Scheme 4-1: Different synthetic routes to ZnTBP, 5 
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Milder synthetic methods have since been explored
10
. Recently, Beletskaya and co-workers came 
up with a method for the synthesis of TBP from 4,7-dihydroisoindole
11
. Using standard Barton-
Zard chemistry, 4,7-dihydroisoindole
11
 was synthesized from (trimethylsilyl)acetylene, 
tosylacetylene and 1,3-butadiene. It was then successfully used in the preparation of TBPs using 
standard Lindsey protocol
11
 as shown in Scheme 4-2.  
 





One of the main areas of concern has been the low solubility of the TBPs. These compounds, for 
example 5, have been found to be insoluble in most organic solvents, which has further led to 
problems with their purification. One way in which this problem can be overcome is by 
introduction of substituents to increase solubility
12
.  
4.2 Polyamine Conjugated TBPs in PDT 
PDT is a bimodial treatment which combines the applications of a photosensitizer and visible 
light to destroy cancerous cells
13
. It is based on two biological properties of PDT drugs; their 
selective accumulation into cancer cells and the photoactivation of the photosensitizer by visible 
light in the presence of oxygen. The singlet oxygen that is generated kills the abnormal tissues
14
, 




, a first generation photosensitizer has been 
used in several countries to treat various cancers
15
. It however suffers several drawbacks, which 
include poor selectivity, leading to death of the surrounding normal cells and also 
photosensitivity of the skin due to slow clearance rate of the photosensitizer, which may last for 
several weeks after treatment
16
. Other drugs that have been developed and approved in different 
countries are Foscan
®





which was approved for the treatment of age related macular degeneration
13
. To improve the 
efficiency of PDT, it is crucial to develop drugs with improved selectivity for tumor cells. 
Porphyrin polyamine conjugates present a promising way to overcome this problem
15
.  
4.2.1 Functions of Polyamines 
Polyamines are components of all cells that are required for cell growth and survival. Because 
they play a critical role in cell proliferation, agents that interfere with polyamine metabolism 
have been developed and studied as potential anti-tumor drugs
17
. Interrupting the polyamine 
metabolic pathway leads to either cessation of cell growth or cell destruction
18
. In mammalian 
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cells, the polyamines spermine, spermidine and putrescene (see Figure 4-3), together with Mg
2+
 
are the main cations in cells. The polyamine levels in cells are regulated by biosynthesis, 
degradation and transport
19
. Uptake of polyamines increases in rapidly proliferating cells
16a
. 
Therefore, tumor cells whereby the polyamine requirements surpass their biosynthetic abilities, 
use the polyamine transport system (PAT) to fulfill their needs. PAT displays a high affinity for 
polyamines and at the same time a low specificity for them. It therefore affords selective 





Figure 4-3: Polyamines found in mammalian cells 
 
Various research groups have shown that polyamine conjugation can be utilized to convey 
cytotoxic drugs into rapidly growing cells
14a, 20
. Cohen and co-workers showed that 
chlorambucil-spermidine conjugate showed greater anti-tumor activity both in vivo and in vitro 
than chlorambucil on its own
20a
. Papadopoulou and co-workers also demonstrated that 
nitroimidazole-based polyamine derivatives could be of great interest as cytotoxins and 
radiosensitizers for their selective uptake by tumor cells through PAT
20c
. Sol and co-workers 
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have also done extensive research on porphyrin-polyamine conjugates for PDT and DNA 
cleavage. Their studies further indicated the importance of amphiphilicity for photodynamic 
activity by the porphyrin-polyamine conjugates
14a
. 
In our research, we focus on the synthesis of TBP. As mentioned before, these compounds are 
known to absorb and emit at longer wavelengths than regular porphyrins. This is critical in the 
development of a photosensitizer that will be used in PDT. We employed a  mixed condensation 
strategy in the preparation of mono- and di-substituted TBPs. In addition, we conjugated the 
TBPs to the polyamines spermine and spermidine, using a short and flexible carbon chain spacer. 
We carried out in vitro studies of these conjugates, and also studied their photophysical 
properties. 
4.3 Results and Discussion 
From the preliminary results obtained by Dr. Martha Sibrian-Vasquez, it was observed that the 
mono-substituted TBP-spermine conjugate recorded low dark toxicity (See Appendix). In 
addition, when exposed to light, it was found to be highly phototoxic, with an IC50 value of 
1.95μ  at 1 J/cm light dose. Furthermore, the mono-substituted TBP-spermine conjugate 
recorded the fastest and highest cellular uptake of all conjugates tested. So with this in mind, we 
set out to synthesize the di-substituted TBP-spermine conjugates to establish whether it would 
show even better in vitro results. 
We began the synthesis with the preparation of the polyamines. We started with the protection of 
spermine using Boc-ON in the presence of triethylamine. Three equivalents of protecting group 
were used to ensure only the terminal amines and one secondary amine reacted leaving one 
secondary amine unreacted. This afforded compound 14 in 92% yield as shown in Scheme 4-3. 
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The next step was introduction of the flexible spacer using N-(4-bromobutyl)phthalimide in the 
presence of base. The target compound 16, was obtained after cleaving the phthalimide-protected 
amine group using hydrazine monohydrate. 
The synthesis of porphyrins 17-19 was carried out by a former group member, Dr. Martha 
Sibrian-Vasquez. After carrying out a condensation reaction using Lindsey‟s method, using 
butanopyrrole, benzaldehyde and methyl 4-formylbenzoate, she obtained the mono-substituted 
product 17, and a mixture of the di-substituted products 18 and 19 (See Scheme 4-4).  
 
Scheme 4-3: Synthesis of Boc-protected spermine 16 
 
Starting with the mixture of substituted products, 18 and 19, we attempted to separate the two 
isomers using column chromatography. This proved to be futile, as the two isomers have similar 
Rf values. We therefore decided to take the mixture of isomers to the next step. We carried out 
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the oxidation of the macrocycle, using DDQ, to give the fully conjugated TBPs, 20 and 21. At 
this stage, it was then possible to separate the two isomers using silica gel chromatography to 
afford the two isomers 20 and 21 (see Scheme 4-5). The next step was the removal of Cu metal. 
This was achieved by dissolving the TBPs in concentrated H2SO4, and allowing the solution to 
stir for 10 minutes. The use of H2SO4 in this case was based on the fact that these TBP-Cu 
complexes belong to the class I porphyrins that are considered to be extremely stable, and 
therefore require a strong acid to remove the Cu metal. Purification of 22 and 23 involved 
filtration of the precipitate, and washing it with a large amount of water. 
The next step was the hydrolysis of the ester groups. This was carried out by refluxing the TBP 
in NaOH solution to afford the final TBPs, 24 and 25, in quantitative yields. 
 






Scheme 4-5: Synthesis of di-substituted TBPs 24 and 25. 
 
Several attempts were made to conjugate the Boc-protected spermine to TBPs 24 and 25. In the 
first attempt, we carried out the conjugation reaction in the presence of DIEA, HOBt, and TBTU, 
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with DMF as the reaction solvent. Unfortunately, we did not get the target compounds, and we 
could not correctly assign the product from NMR or MS (see Scheme 4-6). 
 
Scheme 4-6: First Attempt Synthesis of TBP-polyamine conjugates 
 
In order to facilitate the coupling reaction, we decided to introduce a glycine spacer (see Scheme 
4-7). We started by reacting the TBPs with Boc-protected glycine in the presence of DIEA, 
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HOBt, TBTU and with DMF as the reaction solvent. Unfortunately, purification of the product 
proved to be difficult because of presence of DIEA which was difficult to separate. 
 
Scheme 4-7: Synthesis of TBP-Boc-protected glycine conjugates 26 and 27 
 
We are currently trying to purify 26 and 27. After we obtain the pure compounds, we will 
deprotect the Boc groups using TFA. This will be followed by conjugation of the TBPs with the 
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already synthesized Boc-protected spermine 16. Finally, we will deprotect the Boc- groups to 
obtain the final compounds 28 and 29, as shown in Scheme 4-8. 
 
Scheme 4-8: Synthesis of conjugates 28 and 29. 
 
We decided to prepare the TBPs using a different synthetic route
11
. Our objective was to 
determine whether we could get better yields than before. In addition, we anticipate that we will 
get fewer products, which will make the isolation and purification of the desired products easier. 
It will still be a mixed condensation but starting with 4,7-dihydro-2H-isoindole, rather than 





Scheme 4-9). This was done by deprotecting the trimethylsilane group using NaF at room 
temperature, to afford 30 at 47% yield. Studies have shown that tosylacetylene is a strong 
dienophile, that readily reacts with electron-rich dienes
11, 22
. The next step was a Diels- Alder 
reaction, which involved reaction of the highly reactive acetyl sulfone with 1,3-butadiene at 
room temperature for 48 h, to afford the cyclohexadiene, 31, in 80% yield
11
. We are still working 
on completing the synthesis. In the next step of the synthesis we will use standard Barton-Zard 
chemistry, using compound 31 for the preparation of 32 (see Scheme 4-10). Compound 32 will 
then be used for the preparation of 4,7-dihydroisoindole 33, which will finally be used in the 
synthesis of TBP 22 and 23 using standard Lindsey protocol. 
 








Synthesis of the Boc-protected spermine 16 was carried out successfully. Purification of the 
intermediate steps was easily achieved using silica gel chromatography and the target compound 
obtained in good yields. In addition, synthesis of the di-substituted TBP isomers 24 and 25 was 
successfully carried out. Similarly, purification involved silica gel chromatography using 
differemt EtOAc/Hexane solvent systems for elution. Future work which entails completion of 
TBP synthesis using the alternative route is currently underway. Furthermore, optimization of 




All reactions were monitored by use of thin layer chromatography (TLC) using 0.25mm silica 
gel plates purchased from Sorbent technologies, with or without UV indicator (60F-254). All 





C NMR spectra were obtained either on a DPX-250 or AV-400 Bruker spectrometer. 









C). MALDI-TOF mass spectra were obtained on a Bruker 
OmniFLEX MALDI-TOF mass spectrometer. ESI-TOF was obtained on Agilent 6210. Reagents 
and solvents were obtained from either Sigma-Aldrich or Fischer Scientific, and were used 
without further purification. 
Synthesis of Compound 14 
Spermine (1.0g, 4.94 mmol) was dissolved in anhydrous THF (40 mL). The solution was then 
cooled to 0
o
C. Boc-ON (3.7g, 14.8 mmol) was dissolved in THF (40 mL) and the solution added 
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dropwise to the spermine solution, under argon. Et3N (2.0g, 19.8 mmol) was added in one 
portion and the reaction mixture stirred for 20h at 0
o
C. After 20h the solvent was evaporated 
under vacuum and the residue dissolved in DCM. The resulting solution was then washed twice 
with 5% NaOH, and then water. The organic phase was dried over Na2SO4, filtered and the 
product purified by flash chromatography, using 20%CHCl3/Hexane. Yield 2.3g, 92%. 
1
H NMR 
(CDCl3, 400 Hz) δ 5.24  2H, br s), 3.67  4H, m), 3.12  4H, m), 2.52  4H, m), 1.81  4H, m), 
1.58 (4H, m), 1.27 (27H, s). 
13
C NMR (acetone-d6, 100MHz) 168.0, 78.5, 77.6, 53.2, 51.7, 46.8, 
44.6, 38.8, 37.4, 36.8, 34.2, 26.5, 23.9, 23.5. ESI-TOF calcd for C25H50N4O6 502.69, found 
503.38. 
Synthesis of Compound 15 
Boc-protected spermine (2.0g, 3.98 mmol) and N-(4-bromobutyl)phthalimide (1.35g, 4.78 
mmol) were dissolved in anhydrous CH3CN (100 mL) and the reaction mixture put under argon. 
K2CO3 (5.6g, 19.9 mmol) was then added to the reaction mixture in one portion, after which the 
reaction mixture was refluxed for 24h. The reaction mixture was then allowed to cool to room 
temperature, followed by solvent removal under vacuum. The solid residue was dissolved in 
DCM and then washed twice with saturated NaHCO3, then water, and finally dried over Na2SO4. 
The solvent was evaporated under vacuum, after which the product was purified by column 
chromatography using 20%CHCl3/Hexane to afford 89% yield. 
1
H NMR (CDCl3, 400 Hz) δ 
7.78 (2H, d, J= 3.5Hz), 7.66 (2H, dd, J= 3.5Hz, J= 3.5 Hz), 5.33 (2H, br s), 3.65 (4H, m), 3.38 
(2H, t), 3.2 (2H, br s), 3.09 (4H, m), 2.35 (4H, m), 1.83 (4H, m), 1.60 (8H, m), 1.38 (27H, s). 
13
C 
NMR (acetone-d6, 100MHz) 168.0, 155.7, 134.1, 132.3, 122.9, 78.5, 77.5, 58.6, 52.9, 51.5, 46.7, 




Synthesis of Compound 16 
Compound 15 (1.0g, 1.42 mmol) and hydrazine monohydrate (3.56g, 71.0 mmol) were dissolved 
in 25 mL of a mixture of THF/MeOH (8:2). The reaction mixture was stirred under a nitrogen 
atmosphere at 90
o
C for 5 h, and then at 50
o
C for 18 h. The reaction mixture was allowed to cool 
to roon temperature, and the solvent was evaporated under vacuum and the residue dissolved in 
CH2Cl2. The organic phase was washed with 5% aqueous NaOH (3 x 100 mL), H2O (3 x 100 
mL), and finally dried over Na2SO4. The solvent was evaporated under vacuum and the product 
purified by column chromatography on silica gel using 3% NH4OH/MeOH. Yield 0.39g, 48%%. 
1H NMR (CDCl3, 400 Hz) δ 5.32  2H, br s), 5.30  1H, br s), 3.58  4H, m), 3.24  2H, t), 3.18 
(2H, br s), 3.04(4H, m), 2.24 (4H, m), 1.80 (4H, m), 1.58 (8H, m), 1.37 (27H, s). 
Synthesis of Compound 20 and 21 
The mixture of isomers (0.26g, 0.258 mmol) was dissolved in 32 mL anhydrous toluene. DDQ 
(0.59g, 2.58 mmol) was added to this solution and the resulting mixture refluxed for 30 minutes. 
The reaction mixture was then allowed to cool to room temperature, and diluted with CHCl3. It 
was then washed with saturated NaHCO3, water and finally dried over Na2SO4. The solvent was 
removed under vacuum, and the resulting product purified by column chromatography using 
CHCl3, to afford 0.05g and 0.086g of 20 and 21 respectively.. HRMS m/z calcd for 
C64H40CuN4O4 991.2340, found 991.2325 and 991.2340 respectively. 
Synthesis of Compound 22 
Compound 20 (0.075g) was dissolved in concentrated H2SO4 (5 mL). The solution was allowed 
to stir at room temperature for 10 minutes. It was then poured in ice/water. The resulting mixture 
was extracted with CHCl3, dried over Na2SO4, and dried under reduced pressure. The final 





(CDCl3, 400 Hz) δ 8.67  4H, m), 8.47  6H, m), 8.03  4H, m), 7.85  4H, m), 7.45  8H, m), 7.33 
(8H, m), 4.12 (6H, s). 13C NMR 167.5, 136.2, 135.9, 131.6, 131.2, 130.3, 129.5, 129.3, 124.2, 
52.0. HRMS m/z calcd for C64H42N4O4 931.3279, found 931.3271. 
Synthesis of Compound 23 
Procedure similar for Compound 22. Starting with compound 21 (0.086g), Yield 73% 
1
H NMR 
(CDCl3, 400 Hz) δ 8.59  4H, m), 8.42  6H, m), 8.00  4H, m), 7.90  4H, m), 7.46  8H, m), 7.30 
(8H, m), 3.90 (6H, s). HRMS m/z calcd for C64H42N4O4 931.3279, found 931.3259. 
Synthesis of Compound 24 
Compound 22 (0.050mg, 0.054 mmol) was dissolved in 8 mL of a mixture of 1:1 2M 
NaOH/THF. The mixture was refluxed for 4h. It was then allowed to cool to room temperature 
and 1N HCl used to acidify the reaction mixture to pH 4-5. The precipitate that formed was 
filtered and washed with water until pH was neutral. Yield 92%. 
1
H NMR (acetone-d6, 400MHz) 
δ 10.8  2H, s), 8.45  4H, m), 8.03  6H, m), 7.56  4H, m), 7.23  4H, m), 7.18  8H, m), 7.10  8H, 
m). HRMS m/z calcd for C62H38N4O4 903.2966, found 903.2970. 
Synthesis of Compound 25 
Procedure similar Compound 24. Starting with compound 23 (0.070g, 0.075mmol), Yield 93%. 
1
H NMR (acetone-d6, 400 Hz) δ 10.7  2H, s), 8.52  4H, m), 8.05  6H, m), 7.58  4H, m), 7.27 
(4H, m), 7.22 (8H, m), 7.13 (8H, m). HRMS m/z calcd for C62H38N4O4 903.2966, found 
903.2961. 
Synthesis of Tosylacetylene (30) 
p-Tolyl-2-(trimethylsilyl)ethynyl sulfone (0.9g, 3.56 mmol) was dissolved in EtOH (18 mL) and 
the solution cooled to 0
o
C. A chilled solution of NaF (0.45g, 10.7 mmol) in 6.75 mL water was 
then added dropwise to the sulfone solution. The reaction was then allowed to warm to room 
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temperature. It was allowed to stir for 3h. It was then extracted with hexane to afford the title 
compound in 47% yield. 
1
H NMR (CDCl3, 400 Hz), δ 7.90  2H, d, J= 8Hz), 7.40  2H, d, J= 
8Hz), 3.44 (1H, s), 2.48 (3H, s).  
Synthesis of 1-(cyclohexa-1,4-dien-1-ylsulfonyl)-4-methoxybenzene (31) 
A heavy walled pressure tube was placed in an ice/salt bath, and the temperature maintained at -
10
o
C. 1,3-butadiene (5ml, 59.22 mmol) was the added to the flask. tolylacetylene (0.2g, 1.02 
mmol) was then added to the reaction vessel, and the pressure tube sealed tight. The reaction 
mixture was allowed to warm to room temperature, after which it was allowed to stir for 48h. 
The reaction vessel was then cooled to -10
o
C for the excess 1,3-butadiene to condense back to 
liquid form. It was then evaporated slowly, and the residue purified by column chromatography 
using 1/10 EtOAc/hexane to afford the title compound in 80% yield. 1H NMR 7.75 (2H, d, J= 
8Hz), 7.43 (2H, d, J= 8Hz), 6.99 (1H, s), 5.67 (2H, d, J= 11Hz), 2.95 (2H, s), 2.76 (2H, d, J= 
8Hz), 2.42 (3H, s). 
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APPENDIX: PRELIMINARY RESULTS 
 
Preliminary results  obtained by Dr. Martha Sibrian-Vasquez 
 
Figure 5-1: Structures of studied TBPs MSV 8-90, MSV 9-28 and MSV 9-30 
 
 
Figure 5-2: Phototoxicities of TBPs MSV 8-90  ■), MSV 9-28  ▲) and MSV 9-30  ▼) toward 




Figure 5-3: Dark Toxicity of TBPs MSV 8-90  ■), MSV 9-28  ▲) and MSV 9-30  ▼) toward 
HEp2 cells using Titer Blue assay. 
 
 






            MSV8-90                           MSV 9-28 
Figure 5-5: Subcellular localization of MSV 8-90 and MSV 9-28 in HEp2 cells at 10μ  for 24 
h. (a) Phase contrast, (b) overlay of MSV 8-90 and MSV 9-28 and phase contrast, (c) ER-tracker 
green fluorescence (e) MitoTracker Green Fluorescence (g) LysoSensor Green fluorescence, (i) 
BODIPY Ceramide fluorescence, (d), (f), (j) overlays of organelle tracers with MSV 8-90 and 





          MSV 9-30 
Figure 5-6: Subcellular localization of MSV 9-30 in HEp2 cells at 10μ  for 24 h.  a) Phase 
contrast, (b) overlay of MSV 9-30 and phase contrast, (c) ER-tracker green fluorescence (e) 
MitoTracker Green Fluorescence (g) LysoSensor Green fluorescence, (i) BODIPY Ceramide 
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